Podcasts about Northwestern

The Minnesota Frost freeze out the Ottawa charge and are back-to-back PWHL Walter Cup Champions. Every game in the series went into overtime. UNC beats Northwestern to win the NCAA Lacrosse Championship. It is a family affair on so many levels. Plus, there is a Cowboy Carter Cameo as Danielle and Carolyn got rowdy at Beyonce's concert this past week, cowboy hats and all.Schedule update! Women's Sports Weekly will begin releasing on Wednesdays beginning June 4th. If you rate Women's Sports Weekly 5 stars, send a screenshot and you will receive a sticker!SUBSCRIBE TO WOMEN'S SPORTS WEEKLY YouTubeSpotifyApple Podcasts  FOLLOW WOMEN'S SPORTS WEEKLY ON SOCIALInstagramTikTokCONTACT WomensSportsWeeklyPod@gmail.com Women's Sports Weekly is created, produced, edited, and hosted by Carolyn Bryan and Danielle Bryan. Music is by the talented ⁠Melvin Alexander Black.⁠

Randy and Cody are reporting for class as Prof. Perez details the history of the US Women's Open ahead of this week's championship at Erin Hills.  We begin the pod with a quick recap of the announcement of the new LPGA Commissioner, Craig Kessler, and a recap of Northwestern's upset of Stanford in the NCAA women's golf team championship match. From there Jordan takes us through the 79 year history of the US Women's Open covering the notable winners and eras of dominance, the close calls and several stories that you're likely never heard before.  Join us in our support of the Evans Scholars Foundation: https://nolayingup.com/esf Support our sponsors: Titleist Omni Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of The Wholesome Fertility Podcast, I am joined by Dr. Nirali Jain (eggspert_md), a board-certified OB/GYN and reproductive endocrinologist at Reproductive Medical Associates (RMA). Dr. Jain shares her expert insights on fertility preservation for individuals undergoing cancer treatment, a crucial yet often overlooked aspect of reproductive care. We explore what options are available for fertility preservation, including egg and sperm freezing, and why it's so important to initiate these discussions before starting chemotherapy or radiation. Dr. Jain also explains the difference between Letrozole and Clomid, the impact of estrogen-sensitive cancers on IVF treatments, and innovative approaches like random-start cycles and DuoStim protocols. Whether you're facing a cancer diagnosis or simply thinking proactively about your reproductive future, this conversation is filled with knowledge and reassurance. Key Takeaways: Why it's essential to discuss fertility before starting cancer treatment. The role of Letrozole in estrogen-sensitive cancers and fertility preservation. Differences between Letrozole and Clomid, and why Letrozole is often preferred. How new protocols like DuoStim and random-start cycles are improving outcomes. Why fertility preservation is important even for those without a cancer diagnosis. Guest Bio: Dr. Nirali Jain (@eggspert_md) is a board-certified OB/GYN and fertility specialist at Reproductive Medicine Associates (RMA) in Basking Ridge, New Jersey. She earned both her undergraduate degree in neurobiology (with a minor in dance!) and her medical degree from Northwestern University, before completing her residency at Weill Cornell/NYP, where she served as co-Chief Resident, and her fellowship in reproductive endocrinology and infertility at NYU Langone. Deeply passionate about women's health and fertility preservation, Dr. Jain blends the latest research and cutting-edge treatments with compassionate, patient-centered care. Her interests include third-party reproduction and oncofertility, and she is especially passionate about supporting patients navigating fertility preservation through a cancer diagnosis. Outside of the clinic, Dr. Jain is a trained dancer, a dedicated global traveler, and an adventurer working toward hiking all seven continents with her husband. Her diverse experiences, from international medical rotations to personal connections with friends and family navigating infertility, have shaped her into a warm, resourceful, and determined advocate for her patients. Links and Resources: Visit RMA websiteFollow Dr. Nirali Jain on Instagram For more information about Michelle, visit www.michelleoravitz.com To learn more about ancient wisdom and fertility, you can get Michelle's book at: https://www.michelleoravitz.com/thewayoffertility The Wholesome Fertility facebook group is where you can find free resources and support: https://www.facebook.com/groups/2149554308396504/ Instagram: @thewholesomelotusfertility Facebook: https://www.facebook.com/thewholesomelotus/ Disclaimer: The information shared on this podcast is for educational and informational purposes only and is not intended as medical advice. Please consult with your healthcare provider before making any changes to your health or fertility care. --  Transcript:   # TWF-Jain-Nirali (Video) ​[00:00:00]  **Michelle Oravitz:** Welcome to the podcast Jain.  **Dr. Nirali Jain:** Thanks so much for having me **Michelle Oravitz:** Yeah, so. **Michelle Oravitz:** I'm very excited to talk about this topic, which, um, actually you don't really hear a lot of people talking about, which is how to preserve your fertility if you're going through a cancer diagnosis and if you have to go through treatments. 'cause obviously that can impact a lot on fertility. **Michelle Oravitz:** I have, um, seen actually like a colleague of mine go through. And she also preserved her fertility and, and now she has a baby boy. so it's really nice. **Michelle Oravitz:** to **riverside_nirali_jain_raw-video-cfr_michelle_oravitz's _0181:** so nice. **Michelle Oravitz:** So I'd love for you first to introduce yourself and kind Of give us a background on how you got into this work. **Dr. Nirali Jain:** Of course. Um, so I am Dr. Narly Jane. I am, um, an OB GYN by training, and then I did an additional, after completing four years of residency in OB GYN and getting board certified in that, I did an additional training in reproductive endocrinology and [00:01:00] infertility or otherwise known as REI. So now I'm a fertility specialist. **Dr. Nirali Jain:** Um, I trained at Northwestern in Chicago, so I went to undergrad and medical school there. And then, um, home has always been New Jersey for me, so I moved back out east to New Jersey. Um, I did all my training actually in New York City at Cornell for residency and NYU for fellowship. Um, and then moved to the suburbs. **Dr. Nirali Jain:** Um, and now I'm a fertility specialist in, in Basking Ridge at Reproductive Medical Associates.  **Michelle Oravitz:** Very impressive background. That's awesome.  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** I'd love to hear just really. About what your process is. If a person has been diagnosed with cancer, like what is the process? What are some of the things that you address if they are trying to preserve fertility, and what are some of the concerns going  **Dr. Nirali Jain:** yeah, yeah. All great questions. So, you know, there's a lot of us, uh, the Reis. Are a very small, [00:02:00] there's a very small number of us. So in terms of specializing in fertility preservation, technically we all are certified to treat patients with cancer and kind of move them through fertility preservation before starting chemotherapy. **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** Um, luckily we've been working closely with oncologists in the past several years just to establish some type of streamlined system because having a diagnosis of cancer and hearing all that information. Especially when you're young is so hard. So I think that's, that's where my interest started in terms of being able to speak to and counsel cancer patients. **Dr. Nirali Jain:** I think it is a very specific niche that you really have to be comfortable with in our field. Um, I. So I'll kind of walk you through, you know, what it, what does it look like, right? Um, you go into your oncologist's office suspecting that you have this, this lump. I'll take breast cancer, for example. It could really be any kind of cancer. **Dr. Nirali Jain:** Um, but breast cancer in a reproductive age patient or someone that's in those years where you're starting [00:03:00] to think about building a family, planning a family, um, or if you have kids at home, that's usually the type of patient that we see come in with a breast cancer diagnosis. So. Kinda just taking that, for example, um, the minute that you're diagnosed, it's really your oncologist's responsibility to counsel you on what treatment options are going to be offered to you. **Dr. Nirali Jain:** And then based off of the treatment options, it's important to know how that affects your reproduction. So how does it affect your ovaries in the short term, in the long term, um, in any way possible. So. Once a patient is initially referred from their oncologist to myself or any other fertility specialist, they come into my office and we just have a 30 minute conversation really talking about family planning goals. **Dr. Nirali Jain:** Any kids that they've had in the past either naturally conceived or through um, IVF, and then we talk about where they're at in their relationship. Are they married, are they not? Are they with a partner, [00:04:00] a male partner, a female partner, whatever it might be. It's important to know the social standpoint, um, especially in this sensitive phase of life. **Dr. Nirali Jain:** So patient patients usually spend anywhere from 30 minutes to an hour. Um, just kind of talking through where they're at, how they're feeling, what their ultimate childbearing goals are. And then from there we do an ultrasound and that's when I'm really able to see, you know, the, the reproductive status. **Dr. Nirali Jain:** So what do the ovaries look like? What does the uterus look like? Is there something that I need to be concerned about from a baseline GYN standpoint? Um, and all of those conversations are happening in real time. So. I think one of the things is patients come in and they're like, I'm already so overwhelmed with all this information from my oncologist, and now my fertility specialist is throwing all this information at me. **Dr. Nirali Jain:** Luckily, the way I like to frame it is you come in and you just let go. Like you let us do the work because in the background we're the ones talking to your oncologist. We're the [00:05:00] ones giving that feedback and creating a timeline with your oncologist. Um, and really I think just getting in the door is the hardest part. **Dr. Nirali Jain:** So once patients are here to see us, we go through the whole workup. We do anything that we would do for a normal patient that came in for fertility preservation. And then based off of where they're at in their journey, we talk about what makes sense for them, whether that means freezing embryos, freezing eggs, they're very similar in terms of the, the few weeks leading up to the egg retrievals. **Dr. Nirali Jain:** So I have that whole conversation just at the initial visit. And then from there we talk about the timeline behind the scenes and make sure that it works with their lives before moving forward. **Michelle Oravitz:** So for people listening to this, why, and this might be an obvious question, but to some it might not be,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** why would somebody want to preserve. eggs or sperm. 'cause I've had actually some couples  **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** come to me where the husband preserved the sperm and they had to go through IVF just because he was going [00:06:00] through cancer treatments. So he had to preserve the sperm ahead of time.  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** people need to consider doing that before doing cancer treatments?  **Dr. Nirali Jain:** So there are certain cancer treatments that do affect the ovaries and the sperm health, and you know, for men and women, it affects your reproductive organs. In a similar way, um, depending on the type of chemotherapeutic agent, there are some that are more dangerous in terms of, um, being toxic to your ovaries or toxic to your sperm. **Dr. Nirali Jain:** And those are the instances where we are really thinking about what's the long-term impact because there's medications that oncologists do give patients, and our oncologists are amazing, the ones that we work with, Memorial Sloan Kettering from Reproductive Medical Associates through RMA, um, and. **Dr. Nirali Jain:** They're just so good at what they do and are so well-trained, so they know in the back of their mind, is this going to impact your ovaries or your sperm health or not? Um, and I [00:07:00] think that any chemotherapy, you know, your ovaries are these, these small organs that are constantly turning over follicles every month. **Dr. Nirali Jain:** So every month we're losing those eggs, and if they don't become. If an egg isn't ovulated, it doesn't become a baby, it's just gonna die off. So I counsel even patients that don't have cancer, I counsel them on fertility preservation as young as possible. You know, between the ages of 28 and 35, that's like the best time to preserve your fertility. **Dr. Nirali Jain:** So in cancer patients, there's an extra level added to that where even if they are a little bit younger, a little bit older. Your eggs are not gonna be the same quality. There's gonna be higher level of chromosomal errors, more DNA breakage, um, and, and bigger issues that lead to issues with conceiving naturally afterwards. **Dr. Nirali Jain:** So I think that it's important to consider how that chemotherapy is going to affect them or how surgery would affect them if it was, for example, a GYN cancer where [00:08:00] we're removing a whole ovary, you know, what, what do we have to do to preserve your fertility in that case? And those are important conversations to have. **Michelle Oravitz:** Yeah. for sure. I know that a lot of people are also concerned, you know, with going through the IVF process, you're taking in a lot of estrogen, a lot of hormones, and many cancers are actually estrogen sensitive. So I wanted to talk to you about that. 'cause I know that the data shows that it's. It's been fine, which some people might find surprising, but I wanted you to address that and just kind of **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** from your perspective.  **Dr. Nirali Jain:** That's so interesting that you asked that question because I actually, my whole I I graduated fellowship last year and my entire, like passion project in fellowship was looking at one of the drugs that we use to suppress the estrogen levels specifically in cancer patients. Um, and I had presented this at a few of our reproductive meetings. **Dr. Nirali Jain:** Um, A SRM is one of our annual meetings where all of the reiss get together. A lot of male fertility [00:09:00] specialists come and we kinda just talk about. Specific things and fertility preservation for cancer patients is, has been an ongoing topic of interest for all of us. Um, and it's important to know that there are different medications that we can offer. **Dr. Nirali Jain:** Letrozole is the one that I, um, have a particular love for and I, uh, you know, I use all the time for my patients, um, for different reasons, but it suppresses the exposure that your body has to estrogen. And there's mixed data, um, out there in terms of, you know, does Letrozole suppression actually impact, you know, does it help or. **Dr. Nirali Jain:** Or does it have no impact on your future risk of cancer after treatment? Um, and that honestly is still up for debate. But what we do know is that there's no increased risk of cancer recurrence in patients that have undergone fertility preservation with or without Letrozole. Um, Letrozole is one of those things that we can give, and the way it works is basically. **Dr. Nirali Jain:** It masks that [00:10:00] conversion. It, it doesn't allow for conversion from those androgens in the male hormones over to estrogen. Um, and so your body doesn't really see that estrogen exposure. It stays nice and low throughout your cycle, and it does help with actually ovarian maturation and getting mature eggs harvested and, um, helps a little bit with, with quality too. **Dr. Nirali Jain:** So I think that it's really nice in terms of having that available to us, but know that. It's not, it's not essential that you have it, really, the data showing plus minus. Um, but there are certain things that we can do to protect the ovaries, protect your exposure to estrogen. Um, and so that shouldn't be top of mind of concern when we're going through fertility preservation, even with an estrogen sensitive cancer. **Michelle Oravitz:** Actually, so, uh, on a different topic, kind of going back to that, so Letrozole versus Clomid, I, it's like a, the questions I personally feel just based on what I've heard and like my own research that Letrozole would be kind of like the more. [00:11:00] Um, the, it's, it's a little better, but I know that it really depends on the person as well.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** they might do better with Clom, but I'd love to hear your perspective and kind of pick your brain on this.  **Dr. Nirali Jain:** totally. You're choosing all the, all the right questions because these are all of my, my specific interests and niches. So  **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** Letrozole is basically, you know, we use Letrozole and Clomid in. Patients that don't have cancer and patients that come in for an intrauterine insemination, that's kind of the most common scenario where we're thinking about, you know, which medication is better? **Dr. Nirali Jain:** Letrozole or Clomid and Clomid used to be the, the most common medication that we use, we dose patients, you know, have 50 milligrams of Clomid, give them five days of the medication. It's an oral pill. Feels really easy and. The way it works is really, it recruits more than one follicle, so it really helps with the release of, um, more than one follicle growing more than one follicle in the ovary. **Dr. Nirali Jain:** Um, but it has a little bit [00:12:00] higher of a risk of twins because that's exactly what it's good at. Um, Clomid, not so much in the cancer. In the cancer front, it's not really used there because it's considered, from a scientific perspective, it's considered like a selective estrogen receptor modulator. So it doesn't necessarily suppress your estrogen levels in the same way that Letrozole does versus. **Dr. Nirali Jain:** Letrozole is an aromatase inhibitor, so it really blocks the chemical conversion of one drug or one hormone to the other hormone. Um, the reason we love Letrozole so much, and I don't mean to like gush over Letrozole, but um, it's a mono follicular agent, so it works really well at recruiting one follicle  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** you know, every OB-GYN's nightmare in a way is having multiples when you didn't intend on having multiples at all. **Michelle Oravitz:** so  **Dr. Nirali Jain:** Um. **Michelle Oravitz:** were saying that, um, there's more of a chance of twins, it's Clomid, not letrozole.  **Dr. Nirali Jain:** Yes, there's a higher chance with Clomid versus Letrozole. And I mean, don't get me wrong, there's a chance of twins with [00:13:00] any type of assisted reproductive technology. Even when we're doing single embryo transfers, there's a chance that it's gonna split. So, um, the chance is always there just like it is in the natural world. **Dr. Nirali Jain:** But we know for a fact that. CLO is really good at recruiting many follicles. It's good for certain patients that don't respond well to Letrozole. Um, but Letrozole is kind of our, our go-to drug these days just because of all the benefits that we've seen.  **Michelle Oravitz:** Awesome.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** These are all fun things to ask because I, I love talking to our eis 'cause there's so much information that I'm always  **Dr. Nirali Jain:** totally. **Michelle Oravitz:** learn a lot from my patients in my own research, but it's really cool. Picking your guys' brains. So another question I have, and I have actually talked to Dr. Andrea Elli, he's been on,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** and he does a lot of endometriosis and, and immune related work as well,  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** so. I'd love to know just from your perspective. One thing that I do know from, based on what I've heard is that the, [00:14:00] guess like you were just saying, that breast cancer or estrogen sensitive breast cancer doesn't seem to be affected by IVF cycles, however, and endometriosis lesions do get affected.  **Dr. Nirali Jain:** Yeah. **Dr. Nirali Jain:** that's a great question. So, you know, every, there are so many complex G mind diagnoses that the, that our patients come in with. Um, and endometriosis is a big one because there is clear data that endometriosis is linked to infertility. So we think about, you know, when a patient comes in with endometriosis, we really do think about the different treatment options and what are the short-term and long-term impacts of the hormones that we're giving 'em. **Dr. Nirali Jain:** Um, these days, again, kind of going back to Letrozole, we, letrozole is something that I give all of my endometriosis patients because it helps suppress their estrogen because we know.  **Michelle Oravitz:** interesting.  **Dr. Nirali Jain:** is very responsive to estrogen and leads to this dysfunctional regulation of all the endometrial tissue that can really flare in a, [00:15:00] in a cycle, or shortly after a cycle. **Dr. Nirali Jain:** I. So we really, for endometriosis patients, the, the best treatment is being on birth control because we don't see that hormonal fluctuation. The up and down of the estrogen and the progesterone, that's what leads to those flares. Um, so I really, I watch patients closely after their cycles too, because you definitely can have an endometriosis flare and we say the best treatment for endometriosis is pregnancy, right? **Dr. Nirali Jain:** That's when you're suppressed, that's when you're at your lowest. Um, and patients, my endo patients feel so good in pregnancy because they have. Hormones that are nice in that baseline, they're not getting periods of course. Um, and that's truly, truly the best treatment.  **Michelle Oravitz:** That's interesting.  **Dr. Nirali Jain:** But it is important to consider when you're going through infertility treatments. **Dr. Nirali Jain:** How does my endometriosis affect the short and long-term effects of the fertility medications? And really not to, not to say that they're bad in any way. I think a lot of endometriosis patients go through IVF and have success and do really, really well, and that's kind of the push that they need. [00:16:00] Um, but it's important to be mindful of the bigger picture here. **Dr. Nirali Jain:** It's not just, you're not just a number of. A patient with endo coming in, getting the same protocol. It's really individualized to the extent of your lesions, what symptoms you're having, what grade of endometriosis, where your lesions are. So we're the RAs are thinking about everything before we actually start your protocol. **Michelle Oravitz:** It's crazy how in depth it is, and it's, it, there's just so, it's so multifaceted,  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** when it's females  **Dr. Nirali Jain:** totally. **Michelle Oravitz:** are a little, I mean, they can, you know, there, there's definitely a number of things, but it's not as complicated and interconnected  **Dr. Nirali Jain:** Exactly. Exactly. That's so true. **Michelle Oravitz:** And so one question I actually have, this is kind of really off topic, but something that I was curious about. **Michelle Oravitz:** 'cause I heard about a while  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** a, a type of cancer treatment that was used. I'm not sure exactly what it was, but for some reason it actually caused follicles to grow, [00:17:00] or to multiply. And they were **Dr. Nirali Jain:** Interesting. **Michelle Oravitz:** this definitely. Puts, um, the whole idea of like a woman being born with all the follicles she'll ever have on its head, I thought that was really Interesting. **Michelle Oravitz:** Now I learned a little bit about it. I don't think it really went further than that,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** one of those things that they're like, Hmm, this is interesting. I don't know, it was kind of a random side effect of this chemo drug. I dunno if it was a chemo drug or a cancer drug.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** ever heard of that. **Michelle Oravitz:** So I was just **Dr. Nirali Jain:** I haven't, I mean, that's interesting. I feel like I'd have to look into that because that would be definitely a point of interest for a lot of Reis. But it kind of does go back to the point of, you know, women are really born with all the eggs we're ever gonna have. So it's about a million, and then it just goes down from there. **Dr. Nirali Jain:** And the, by the time you start having periods, I like to kind of show my patients a chart, but you have a couple hundred thousand eggs and you ovulate one egg a month. That's, you know. Able to [00:18:00] progress into a fertilized egg and then into a, an embryo into a baby, um, if that's your goal. But otherwise, patients that are having periods and not trying to actually get pregnant, we're losing hundreds of eggs a month. **Dr. Nirali Jain:** So.  **Michelle Oravitz:** Mm.  **Dr. Nirali Jain:** It's important to kind of think about that decline, and it's important to know that that rate can be faster in patients with cancer, patients with low ovarian reserve. And sometimes when you have the two compounded, that's when a fertility specialist is definitely, you know, in the queue to, to have a discussion with you in terms of what that means and how you can reach your family building goals despite being faced with that, with that challenge. **Michelle Oravitz:** Yeah. **Michelle Oravitz:** I mean, 'cause we know oxidative stress is one of the things that can cause, uh,  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** quality eggs, but it's also can cause cancer. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** um, similar, you know, like things that really deplete the body could definitely impact. Um, and then what are your thoughts? I know I'm asking you all kinds of random questions, **Dr. Nirali Jain:** I love it. **Michelle Oravitz:** are your thoughts about doing low simulation in certain [00:19:00] circumstances versus high stem? **Michelle Oravitz:** Sometimes people don't respond as well to higher stems.  **Dr. Nirali Jain:** Yeah, that's a great point. I think that it kind of all goes back to creating an individualized protocol. If. A patient's going to a practice and basically just getting a protocol saying, this is our standard. We start with our standard of, you know, I, I think about the standard, which is 300 of the FSH or that pen that you dial up, and then 150 units of that powder vial. **Dr. Nirali Jain:** And we have patients mixing powders all the time, and that's kind of our blanket protocol that we give patients. But that's not really what's happening behind the scenes. And if you're given a protocol that's, and being told, you know, this is kind of what we give to everyone, it's probably not the right fit for you. **Michelle Oravitz:** Yeah, I  **Dr. Nirali Jain:** Um, there are certain patients that respond to a much lower dose and do really, really well, and then some patients that need a much higher dose. Um, and I think it's, that's kind of like the fun part of being an REI of being able to individualize the [00:20:00] protocol to the patient. Um, and I know for a fact there are so many, luckily, you know, we have so many leaders in REI that have been. **Dr. Nirali Jain:** Have dedicated their entire careers to researching these different protocols and how they can help different patients. Um, patients with lower a MH, you know, might benefit from a duo stim protocol, for example. That's kind of the first one that comes to mind, but a protocol where we're using those follicles from the second half of a cycle. **Dr. Nirali Jain:** I would've never thought that those were the follicles that  **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** would be better than the first half of the cycle,  **Michelle Oravitz:** Wait,  **Dr. Nirali Jain:** but, **Michelle Oravitz:** that. Explain that. Um, because I think that that's kind of a unique  **Dr. Nirali Jain:** mm-hmm.  **Michelle Oravitz:** that I haven't heard of.  **Dr. Nirali Jain:** Yeah, so there's this new day. It's still kind of developing, but um, kind of going back to, you know, what's an individualized protocol? Duo STEM is one of the newer protocols that we've started using. I, I've used it once or twice in patients. Um, but it goes back to the research that shows that you might actually have two different periods of time in a menstrual cycle where you could potentially recruit [00:21:00] follicles. **Dr. Nirali Jain:** You could have a follicular phase where there's a certain cohort of follicles recruited, and then you have a follicle that forms creates a corpus glut.  **Michelle Oravitz:** um, protocols  **Dr. Nirali Jain:** Yep. And then you basically go through the follicular protocol and then a few days after a retrieval, instead of waiting for a new follicular cohort or follicular recruitment from the first half of your menstrual cycle, you actually use the luteal phase and you recruit those follicles that would've actually died off or have been prematurely recruited in a prior cycle. **Dr. Nirali Jain:** So **Michelle Oravitz:** that's So  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** you just do a similar, I guess, um, medicine,  **Dr. Nirali Jain:** go right back into it.  **Michelle Oravitz:** do the same exact thing, but right after ovulation.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** Fascinating. That's really interesting.  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** has been your experience with that?  **Dr. Nirali Jain:** I think it's, honestly, it's mixed. Um, so far, you know, our data from fertility and sterility and A SRM, it, it shows support for these DUO STEM [00:22:00] protocols, saying that if patients don't have that great quality of eggs or if they have a very low number, maybe they'd benefit from starting the meds earlier and recruiting follicles. **Dr. Nirali Jain:** A little bit earlier. Um, so we've seen positive results so far. A lot of work to be done in terms of really understanding it. Um, and of course, as a new attending, I have a lot more experience to kind of build on. Um, but I, I have seen success from it. **Michelle Oravitz:** That's fascinating. Are there any other new technologies, like new add-ons, um, that you've seen, that you've found to be really cool or interesting?  **Dr. Nirali Jain:** I think the biggest thing, actually, kind of going back to our whole topic for today is fertility preservation cancer patients. One of the biggest things that I've learned recently is that we used to start fertility, um, patients. You know, only in the beginning of the cycle days, two or three is technically like when most. **Dr. Nirali Jain:** Most clinics, um, start patients, but for our cancer patients, sometimes you don't have that time. You don't wanna wait a full month to [00:23:00] restart, um, your, you know, your menstrual cycle and then do the fertility preservation and then delay chemotherapy a full month. So we started doing what we call random starts. **Dr. Nirali Jain:** So you basically start a patient whenever they come in. You know, it could be the day after your consultation, the day of your consultation. I've kind of seen all of the above. Um, and we've seen really good success with random starts, per se. Um, and we've been doing a lot more of that, where it's not as dependent on where you're at in your cycle. **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** Um, obviously there's a difference in outcomes. You might not be a great candidate for it, so definitely it's worth talking to your doctor about it. But it kind of gives relief to our cancer patients where if you have a new cancer diagnosis and you're like, oh, I just finished my period, like, I can't even start a cycle until next month. **Dr. Nirali Jain:** That's not always true. Um, so it's always worth it to go into see a fertility specialist and just get, you know, get the data that you need right away, and then you can make a decision later on. **Michelle Oravitz:** For sure. Um, Yeah. **Michelle Oravitz:** and I wanted to kind of cover a lot of different topics 'cause I know that [00:24:00] some people are gonna wanna hear what you have to say that don't necessarily, or, uh, have cancer. But it is important. I, I think that, you know, if you get to thirties and you haven't gotten married or you don't have a partner, I think it's really important to preserve your fertility in general.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** important thing. And then if you were going through a cancer diagnosis and you decided to preserve your fertility, um, guess more for women because they're eventually going to be thinking about transfers after they go through treatment. So what are some of the things that they would need to consider as far as that goes? **Michelle Oravitz:** Like after the  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** then they go through the cancer treatments. Um, and then what, how long should they  **Dr. Nirali Jain:** yeah. Like what does it look like? So I've had patients that come back, you know, in my fellowship training I did a, a couple research projects on patients that came back to pursue an embryo transfer, um, after chemotherapy agent. And basically compared them to how they did, um, [00:25:00] compared to patients that didn't have cancer and just froze their embryos or froze their eggs and then came back to pursue a transfer and. **Dr. Nirali Jain:** I think the, the most reassuring thing from the preliminary data that we have is saying that there's no difference in pregnancy rates and no difference in life birth,  **Michelle Oravitz:** Awesome.  **Dr. Nirali Jain:** of whether they had chemotherapy or not. After freezing those eggs and going through fertility preservation.  **Michelle Oravitz:** Amazing.  **Dr. Nirali Jain:** Um, in terms of where your body needs to be, I think the oncologist, we, we wait for their green light. **Dr. Nirali Jain:** We wait for their signal to say, you know, she's safe to carry a pregnancy.  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** And then once we do that, we basically treat you like any other patient. So if you're coming in for a cycle, if you're having periods, then it's reasonable to try a natural cycle protocol, wait for your body to naturally ovulate an egg. **Dr. Nirali Jain:** And instead of obviously hoping that egg will fertilize, we, um, use a corpus luteum. We use the progesterone from the corpus luteum to really support this embryo being implanted into the uterus. Um. Yeah. [00:26:00] And then there's also another side. I mean, some patients don't get their periods back and they always ask like, what if I never get my period back? **Dr. Nirali Jain:** What if I'm just like in menopause because of the chemotherapy agents? And for that, we can start you on a synthetic protocol or basically an estrogen dependent protocol where you take an estrogen pill for a certain number of days. We monitor your lining, then we start progesterone, um, to support your hormones from that perspective instead of relying on your ovaries to release the progesterone that they need, um, and then doing the embryo transfer a few, few days after progesterone starts. **Dr. Nirali Jain:** So there's definitely different protocols depending on where your menstrual health is at after the chemotherapy or after the cancer treatment. Um, but it's important to kind of just know that. That there's options. It doesn't mean that it's the end of the road if you all of a sudden stop getting your period. **Michelle Oravitz:** Yeah, for sure. I mean, 'cause you, technically speaking, you can really control a lot of that. More so for transfers  **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** Retrievals really is kind of like what [00:27:00] eggs you have, what the quality is. But people can be in complete menopause and you guys can still control their cycles for transfer, which is kind of. A huge difference  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** in the  **Dr. Nirali Jain:** exactly. That's exactly right. Yeah. **Michelle Oravitz:** interesting. Any other, um, new, new things that you're, you guys are excited about? I always like to hear about like the new and upcoming things  **Dr. Nirali Jain:** Of course.  **Michelle Oravitz:** actually before, which I thought was fascinating. Yeah.  **Dr. Nirali Jain:** I feel like there's always like updates and, and new data and things like that coming out, but just know, I think it's important for patients to know, like we're constantly, we're, the reason I chose to even pursue this field was because it's new. Right. There's something that we are discovering every day, every year, and that's what makes our, our conferences so important to attend, um, to really just stay up to date. **Dr. Nirali Jain:** Um, but we are, uh, constantly updating our embryology standards, the way we thaw our eggs, and the success rate associated with a thaw and [00:28:00] how we treat our embryos and the media that we use, right? Like, so we're really thinking about the basic science perspective every single day, and that's what makes this field so unique. **Michelle Oravitz:** It is really awesome. And so do you guys specialize specifically on, um. Egg freezing and, and I mean specific fertility preservation in patients that do that have cancer that are going through treatments, do you guys specialize specifically in that? I mean, I know you do range  **Dr. Nirali Jain:** Yeah. Yeah, because it's such a small community, we all have our own niches and we all kind of have our own interests and  **Michelle Oravitz:** Yeah.  **Dr. Nirali Jain:** no like specific training. There are a couple courses that you take that I took in in training as well, just to kind of understand what it sounds like to, I. Council of fertility preservation, patient with and without cancer. **Dr. Nirali Jain:** Um, and then, you know, you kind of just learn by experience and you form a niche for something that you're passionate about. 'cause that's what makes you, you know, really thorough in, in your treatment. [00:29:00] So that's one of my interests. Um, and, but I would say,  **Michelle Oravitz:** training for that. It's just like  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** just know how to treat that in  **Dr. Nirali Jain:** exactly.  **Michelle Oravitz:** especially if you're interested in doing that.  **Dr. Nirali Jain:** Exactly. That's exactly right. It's kind of, it just comes with the experience comes with your mentors and who you're surrounded by, and everyone kind of helps each other get to that point. But there are several specialists in our practice at RMA that specialize specifically in fertility preservation in cancer patients. **Dr. Nirali Jain:** So we have a close communication with our oncologist and they know who to refer to within the practice because everyone has their own little interests.  **Michelle Oravitz:** Amazing.  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** Um, definitely. I, like I said, I really enjoy picking your brain because it's a lot of fun for me. I, I do  **Dr. Nirali Jain:** Totally.  **Michelle Oravitz:** acupuncture, so  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** and I, I think that it's just so crazy that our fields don't work together. I mean, we kind of do, but I think, I just feel like it would be so great  **Dr. Nirali Jain:** exactly.[00:30:00]  **Michelle Oravitz:** the expertise because you guys have immense. Benefits like in, in, uh, technology and incredible innovations and, and then the natural aspect of really understanding the, the body. And I, I just think that it would work so amazing together if it was more of like a thing. 'cause it, I know in China they actually combine the two  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** eastern.  **Dr. Nirali Jain:** Yeah, I mean I think that that's so important and there is data that shows, you know, there's actually a recent study that came out just a few weeks ago on the benefits of acupuncture for fertility patients. And we know that, I mean, I recommend it to all of my patients, specifically the day of the embryo transfer. **Dr. Nirali Jain:** We, luckily, we offer it on site at RMA and we have acupuncturists that come in and, and do a session before and after the embryo transfer, and I think. A lot of that is targeted towards stress relief. But I also think that holistically it's important to feel at your best when we're doing something that's so crucial to your, to your health. **Dr. Nirali Jain:** So to really focus on the diet, focus on stress relief, [00:31:00] focus on meditation, yoga, whatever it takes to get to your best wellbeing when you're going through fertility treatments, um, is so important. So I appreciate  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** like you that really specialize in the other side of. Of this, because I do consider it still part of the holistic medicine that we need to really maximize success for our patients. **Michelle Oravitz:** Awesome. Well,  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** Jane, this is such a pleasure Of talking to you. You've given us some, so much great information and we've definitely dived into a, do a topic that I don't typically, I haven't yet spoken about. But, um, that being said, it's such an important topic to talk about. And thank you so much for coming on today. **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** course. **Michelle Oravitz:** I get off, how can people find you?  **Dr. Nirali Jain:** That's a great question. So I have, um, a social media page. I, it's called Expert nc. So like EGG,  **Michelle Oravitz:** I  **Dr. Nirali Jain:** um, expert nc. Try, tried to make it a little bit humorous. Um, but I'm all over social [00:32:00] media and would love to hear from anyone that is listening. I, you know, every, every day I get different, um, dms and I'm happy to respond. **Dr. Nirali Jain:** I love hearing about everyone else's. Stories and things like that. Um, so that is kind of my main, main social media platform. Um, and then through like RMA and Reproductive Medical Associates, we also have a YouTube channel. We have an Instagram page, um, of our office available, um, as well that is public. **Dr. Nirali Jain:** So you can find us pretty easily if you just kind of hit Google. But um, yeah, I'm kind of developing my social media platform as the expert and I hope it grows.  **Michelle Oravitz:** Love it. Great.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** was such a pleasure talking to you. Thank you. so much **Dr. Nirali Jain:** Thank you. **Michelle Oravitz:** today.  **Dr. Nirali Jain:** Of course. Thank you so much for having me.  [00:33:00]   

Making strides against melanoma: how can medical oncologists and interventional oncologists join forces to deliver smarter, patient-centered care? In this episode of BackTable, Dr. Tyler Sandow, hosts Dr. Sunandana Chandra, medical oncologist at Northwestern, and Dr. Riad Salem, interventional oncologist at Northwestern to discuss the evolving management of advanced melanoma. --- This podcast is supported by an educational grant from Replimune. --- SYNPOSIS The doctors open the episode with an overview of melanoma and recent advances in its treatment, highlighting key trials such as DREAMseq and CheckMate 067. The discussion explores the shift from medical oncologist as solo primary providers to a dynamic, multidisciplinary approach to advanced cancer care—emphasizing cutting-edge treatments like immunotherapy and intratumoral oncolytic viruses. Dr. Salem shares practical insights on the procedural techniques of administering intratumoral oncolytics like Replimune, emphasizing the importance of thorough documentation and patient-centered care. The doctors also provide an overview of the ongoing IGNYTE-3 Trial, a Phase 3 study assessing the safety and efficacy of the oncolytic immunotherapy RP1 in combination with nivolumab for the treatment of advanced melanoma. The episode underscores the transformative potential of innovative melanoma treatments and the crucial role of integrated, team-based approaches in improving cancer patient outcomes. --- TIMESTAMPS 00:00 - Introduction03:48 - The Evolution of Melanoma Treatment: From Chemotherapy to Immunotherapy14:05 - The Role of Oncolytic Viruses in Melanoma Treatment20:14 - Interventional Radiology's Role in Cancer Treatment27:00 - Collaborative Approach to Cancer Care32:53 - Hyper Documentation and Communication Efficiency44:47 - Future of Intratumoral Oncolytics48:10 - Multidisciplinary Approach in Advanced Cancer Management51:46 - Conclusion and Final Thoughts --- RESOURCES DREAMseq Trial: Atkins MB, Lee SJ, Chmielowski B, et al. Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134. J Clin Oncol. 2023;41(2):186-197. doi:10.1200/JCO.22.01763 CheckMate 067 trial: Wolchok JD, Chiarion-Sileni V, Rutkowski P, et al. Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. N Engl J Med. 2025;392(1):11-22. doi:10.1056/NEJMoa2407417

This week we move into the arena of preventive cardiology when we review a recent report from the team at Northwestern and Princeton on the impact of early childhood food insecurity on cardiovascular health of people in young adulthood. How does food insecurity in young childhood impact the cardiac health of adults? Why is most of the impact seen on BMI but not other measures of cardiovascular health. How can food programs that support improved food and nutrition security work to improve long term cardiovascular health of children and adults? Do the benefits of such programs outweight their costs? Dr. Nilay Shah of Northwestern University shares his deep insights into his work and these questions this week.DOI: 10.1001/jamacardio.2025.1062

******Support the channel******Patreon: https://www.patreon.com/thedissenterPayPal: paypal.me/thedissenterPayPal Subscription 1 Dollar: https://tinyurl.com/yb3acuuyPayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9lPayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpzPayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9m ******Follow me on******Website: https://www.thedissenter.net/The Dissenter Goodreads list: https://shorturl.at/7BMoBFacebook: https://www.facebook.com/thedissenteryt/Twitter: https://x.com/TheDissenterYT This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/ Dr. Laura Betzig is a Ph.D. in anthropology at Northwestern University; she's held research and teaching positions at Northwestern, the University of California, and the University of Michigan Museum of Natural History.  Her latest book is The Badge of Lost Innocence: A History of the West. In this episode, we focus on The Badge of Lost Innocence. We first discuss how to understand human history as natural history, hunter-gatherer societies, and celibates and sterile castes in Neolithic societies. We then delve into the Roman empire, and talk about the role of eunuchs, emperors and their concubines, and the lives of slaves. We also talk about Medieval Europe, the roles of unmarried and celibate people in the Holy Roman Empire, what happened to bastards, Women's rooms in royal estates, the role of the Church, and the crusades. We discuss Magna Carta and the parliament in England, and how unmarried women were treated in England. We then explore the decline in promiscuity, and people writing against celibacy, as well as colonization and migration. Finally, we discuss what all of this tells us about the history of inequality, and the social role of monogamy.--A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: PER HELGE LARSEN, JERRY MULLER, BERNARDO SEIXAS, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, FILIP FORS CONNOLLY, ROBERT WINDHAGER, RUI INACIO, ZOOP, MARCO NEVES, COLIN HOLBROOK, PHIL KAVANAGH, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, FERGAL CUSSEN, HAL HERZOG, NUNO MACHADO, JONATHAN LEIBRANT, JOÃO LINHARES, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, ROMAIN ROCH, DIEGO LONDOÑO CORREA, YANICK PUNTER, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, NELLEKE BAK, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, HEDIN BRØNNER, DOUGLAS FRY, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, SCOTT, ZACHARY FISH, TIM DUFFY, SUNNY SMITH, JON WISMAN, WILLIAM BUCKNER, PAUL-GEORGE ARNAUD, LUKE GLOWACKI, GEORGIOS THEOPHANOUS, CHRIS WILLIAMSON, PETER WOLOSZYN, DAVID WILLIAMS, DIOGO COSTA, ALEX CHAU, AMAURI MARTÍNEZ, CORALIE CHEVALLIER, BANGALORE ATHEISTS, LARRY D. LEE JR., OLD HERRINGBONE, MICHAEL BAILEY, DAN SPERBER, ROBERT GRESSIS, JEFF MCMAHAN, JAKE ZUEHL, BARNABAS RADICS, MARK CAMPBELL, TOMAS DAUBNER, LUKE NISSEN, KIMBERLY JOHNSON, JESSICA NOWICKI, LINDA BRANDIN, GEORGE CHORIATIS, VALENTIN STEINMANN, ALEXANDER HUBBARD, BR, JONAS HERTNER, URSULA GOODENOUGH, DAVID PINSOF, SEAN NELSON, MIKE LAVIGNE, JOS KNECHT, LUCY, MANVIR SINGH, PETRA WEIMANN, CAROLA FEEST, MAURO JÚNIOR, 航 豊川, TONY BARRETT, NIKOLAI VISHNEVSKY, STEVEN GANGESTAD, TED FARRIS, AND ROBINROSWELL!A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, TOM VANEGDOM, BERNARD HUGUENEY, CURTIS DIXON, BENEDIKT MUELLER, THOMAS TRUMBLE, KATHRINE AND PATRICK TOBIN, JONCARLO MONTENEGRO, NICK GOLDEN, CHRISTINE GLASS, IGOR NIKIFOROVSKI, PER KRAULIS, AND BENJAMIN GELBART!AND TO MY EXECUTIVE PRODUCERS, MATTHEW LAVENDER, SERGIU CODREANU, ROSEY, AND GREGORY HASTINGS!

The Northwestern history professor and New Yorker contributor Daniel Immerwahr joins Tyler Foggatt to discuss the ways in which the COVID crisis deepened Americans' distrust of institutional experts and propelled R.F.K., Jr., to the height of political power in the Trump Administration. Plus, they talk about how Anthony Fauci's clashes and eventual reconciliation with AIDS activists in the nineteen-eighties and nineties could serve as a guide to repairing the rift between Americans who are skeptical of experts and the officials who set public-health policy today.This week's reading:“R.F.K., Jr., Anthony Fauci, and the Revolt Against Expertise,” by Daniel Immerwahr“Who Gets to Be an American?,” by Michael Luo“The Stakes of the Birthright-Citizenship Case,” by Ruth Marcus“Donald Trump's Culture of Corruption,” by Isaac Chotiner“The Mideast Is Donald Trump's Safe Place,” by Susan B. GlasserTune in to The Political Scene wherever you get your podcasts.To discover more podcasts from The New Yorker, visit newyorker.com/podcasts. To send feedback on this episode, write to themail@newyorker.com. Learn about your ad choices: dovetail.prx.org/ad-choices

ISU vs Northwestern, Purdy's Contract Numbers, Bill Fennelly from Tailgate Tour, and more! W H2

The Northwestern crowd leaves Jack and Jeremy wishing they were severed upon entering the ballpark tonight. In a rare game-focused episode, the guys talk about one of the most unruly and annoying crowds to date, with the most outrageous violations occurring in the form of a new category: Photos with Runners in Scoring Position. The guys also head to the bus with hopes of a getaway day autograph haul. Tune in to hear all about it!

Crain's residential real estate reporter Dennis Rodkin talks with host Amy Guth about news from the local housing market, including Dolton's plan to take Pope Leo XIV's childhood home through eminent domain.Plus: The Red Line extension is now a $5.75 billion gamble for the CTA and taxpayers, Motorola Solutions nears $4.5 billion deal for radio maker Silvus, developer proposes residential redevelopment at Blue Man Group's longtime Lakeview home and Northwestern's Kellogg School launching new program for veterans.

"You only sustain a business when your team feels like family and your customers feel like home." In this powerhouse episode of Detroit is Different, entrepreneur and Good Cakes and Bakes founder April Anderson returns to the studio to deliver game like only she can. From rocking Chadsey gear around the Northwestern representer, territory to diving deep into the ever-evolving landscape of Detroit's small business ecosystem, April keeps it raw, insightful, and inspiring. She unpacks what 12 years of entrepreneurship has taught her—especially post-pandemic—about leadership, empathy, culture, and customer service. Whether it's discussing her journey from building an e-commerce platform before it was trendy, maintaining payroll through lean seasons, or how she's learned that she might need to be less of a boss and more of a bridge, this episode is pure gems. April lays out the real on building a team, making tough calls, and the pivot from selling sweets to sustaining community. It's about legacy, leadership, and lemon meringue cupcakes. Don't miss this masterclass in Black business brilliance from one of Detroit's most respected voices. Detroit is Different is a podcast hosted by Khary Frazier covering people adding to the culture of an American Classic city. Visit www.detroitisdifferent.com to hear, see and experience more of what makes Detroit different. Follow, like, share, and subscribe to the Podcast on iTunes, Google Play, and Sticher. Comment, suggest and connect with the podcast by emailing info@detroitisdifferent.com

Steve Grzanich has the business news of the day with the Wintrust Business Minute. One of the country’s top business schools is launching a program to attract more veterans. Northwestern University's Kellogg School of Management has announced The Matt Caldwell Veterans Program. It will focus on increasing veteran student recruitment and provide financial support and […]

Welcome in for another edition of the Morning Espresso, presented by our friends at Oglethorpe University, Atlanta's premier undergraduate learning experience and soccer powerhouse. Wednesday's Europa League Final between Manchester United and Tottenham Hotspur is possibly the most important game in the financial history of Manchester United. It's obviously important in that sense for Spurs as well, it will give them a place at the Champions League table next season, but it's more of a necessity for United. For a club that had the 4th highest amount of revenue in the world last season but still lost £113m, they simply cannot afford to lose out on the over £100m that qualifying for the Champions League guarantees. Because of that and the placement of the two teams in the Premier League table, this match has the feel of a relegation playoff more than a European final. I think it will have that feeling of desperation as well. Kickoff is tomorrow at 3pm, watch on Paramount+. Atlanta United 2 drew 2-2 last night at Crown Legacy after goals from Cayman Togashi and Javier Armas. The 2's are on a 4-match unbeaten run and host Orlando on Friday night at Fifth Third Stadium in Kennesaw. In the NWSL, the Chicago Stars have moved a September match to Northwestern's lakefront Martin Stadium. According to Jeff Kassouf of The Equalizer and ESPN, the Stars' lease is up at SeatGeek Stadium at the end of the year and Northwestern could be in play as a new home for the club. Wednesday night will see the Concacaf W Champions Cup semifinals take place as  Club América host Gotham FC, while Tigres take on Portland Thorns at 10:30 p.m. later that night. The winner of the tournament will qualify for the newly formed FIFA Women's Club World Cup. Speaking of Club World Cup, Flamengo is planning to add Arsenal's Jorginho to their squad for the tournament according to Fabrizio Romano. Inter are still negotiating with Marseille for Luiz Henrique and Real Madrid are closing in on Benfica LB Alvaro Carrera in a 40-50 million Euro deal. It was also announced yesterday that Manchester City will prepare for the tournament at Lynn University in Boca Raton, FL. Expect more announcements like that around the country as teams get ready for the tournament. The first match in Atlanta is set for June 16 as Chelsea will face the winner of the play-in match between Club América & LAFC. New ticket options are available at FIFA.com/tickets. I'll be live on 92.9 The Game tonight with Atlanta Soccer Tonight at 10pm, you can also listen on the Audacy app or on-demand at the Off The Woodwork podcast. More Morning Espresso will be served up on Thursday morning here on the SDH Network.

Back for a second time, Katie Krall is an adjunct lecturer at Northwestern in the Master's of Sports Administration Program teaching “Sports Business: Finance, Accounting, and Economics,” “Sports Organizations: Leadership Theory and Application,” and “Sports Performance and Front Office Operations” and at Medill where she teaches “Sports Marketing.” Katie was previously the Senior Product Manager of Global Baseball Strategy at Hawk-Eye Innovations, a division of Sony Sports Business where she spearheaded development of new products that leveraged biomechanics, player tracking, bat, and ball flight data. Krall spent 2022 as a Development Coach with the Boston Red Sox where she oversaw pitch design, advance scouting and integrating data into player plans. She also was part of the Global Strategy team at Google focusing on Google Workspace after two seasons with the Cincinnati Reds as a Baseball Operations Analyst, a position that combined the worlds of roster construction, analytics, and scouting. After receiving her undergraduate degree at Northwestern, Katie worked for a year and a half at Major League Baseball in the Commissioner's Office in New York City as a League Economics & Operations Coordinator. At MLB, Krall advised Clubs on 40-man roster management, MLB rules and compliance, major league administration, and salary arbitration. In addition to her academic work at Northwestern Katie received her MBA from the University of Chicago's Booth School of Business.

This week host John Kruse brings you audio recorded at the Bighorn Outdoor Adventure Show in Spokane.   1. Josh Contois with the U.S. Fish and Wildlife Service tells you about three National Wildlife Refuges in the region and what you can do while visiting them. 2.  Dave Calhoun with NW Fly and NW Rods tells you about his fishing rods made in Idaho 3.  Cassie Beckley with the Inland Northwest Wildlife Council tells you about their pheasant chick program 4.  TJ Hoffheins previews the Hoyt Archery Mountain Challenge happening this summer at ski resorts in Oregon, Washington and Idaho www.northwesternoutdoors.com     

Host John Kruse was in The Dalles, Oregon for the annual Northwest Outdoor Writers Association conference.  He shares two interviews that won first and second place in the audio/broadcast/podcast category of the annual Excellence In Craft Contest. 1.  Victoria Obermeyer with the Washington Trails Association shares Washington State's best whale watching hikes 2.  Mandy Miles at the Jack O' Connor Hunting Heritage Center shares some stories about this legendary hunting and shooting editor. 3.  We also share another interview that aired last spring with Jason Brooks who has some great advice for turkey hunters. 4. Throw in our regular BirdNote and Extended Mack's Minute and we've got a great show for you!   www.northwesternoutdoors.com www.nowaoutdoors.com    

Preena: Welcome to the Weinberg in the World Podcast, where we bring stories of interdisciplinary thinking in today's complex world. My name is Preena Shroff and I'm your student host of this special Weinberg in the World episode. I'm a third year student majoring in neuroscience and global health studies with a minor in data center. Today I have the pleasure of speaking with Natasha Phillips, who graduated from Weinberg College in 2000 with a Bachelor of Arts in sociology and biology. Natasha currently serves as chief marketing officer for GE Healthcare, leading teams that help healthcare providers design treatment plans for their patients. Natasha, thank you so much for being here with us today. Natasha: Thanks for having me, Preena. It's a pleasure. Preena: We are so excited to learn about your work in healthcare marketing, but would love to start out with how your career path was shaped by your time at Northwestern. Maybe you can tell us more about your undergraduate experience, what were some impactful classes, extracurriculars, or mentorships opportunities that you had which impacted your post-graduate career? Natasha: Yeah. You're making me think a little bit, because I got to go back in time. As an undergraduate, I was super lucky, having both a biology and a sociology major, it gave me the ability to see a very wide range of classes. I wasn't 100% sure actually what I wanted to do. I knew I was somewhat interested in the sciences. I didn't actually know I would be that interested in the social sciences, but I took a couple of classes. One in particular was the Sociology of Race and Ethnicity with Charlie Moskos, which actually made me decide to ... That was the reason I became a sociology major. I just got super lucky, I loved that class. It's funny, if I ever had a second life, I always say I would have loved to have gone back and been a sociology professor. But I didn't take that path, I went more with the actual biology side of things. I was weighing, do I want to do research? I actually was really interested in molecular biology, primarily because in the late '90s, which is a very long time ago to our students who are listening, but for me that was a time very formative because they were sequencing the human genome. There was a lot of promise in the space, not only of biology, but more specifically molecular biology and how it is linked to genetics and genomics as we think about the impact on healthcare. That really interested me to the point where I really was considering actually getting my PhD in molecular biology. Some of my favorite classes were the ones in which I had exposure to research, because I got to see the importance of just the impact that research can have. And the ability to be able to find a practical application, even if it's on a very specific question, to really contribute to the body of knowledge. Ultimately ended up being unsure what I wanted to do right after undergrad, so I went into healthcare consulting in which I wanted to be able to figure out, do I want to go towards the more business side of healthcare and thinking about commercializing healthcare and science from the industry side of things? Or to the academic side and actually get my PhD, and think about contributing to science and healthcare in that realm. I did have exposure, both in consulting as well as in research. I started in a research program at the University of Chicago in molecular biology after doing consulting so I could see both sides. And ultimately, actually, that was when I made the decision to focus much more so on the business side of it and to get my MBA, and to move into healthcare marketing. That led me into the career in which I've had today, in which I've been very lucky to have over 15 years working at very large multinational healthcare companies, primarily in sales and marketing roles, bringing innovation in healthcare to people all over the globe. Preena: Absolutely. Wow, yeah. I think your path is actually not only a common path that students seek out, but also something that students might end up finding themselves in, even if they do experience a career switch in their life. That's really interesting to hear about. I have another question for you, more specifically job-oriented. Healthcare is constantly evolving, so maybe you can tell us a little bit about how your marketing approach has changed since you began your career? Natasha: Yeah. I love that question, Preena, because what really is happening is healthcare is evolving and the function of marketing is evolving constantly. I am really lucky that, both in the subject matter that I basically have decided to focus in, which is healthcare and ultimately the innovation around healthcare, but also have a really cool and exciting function that continues to evolve. I was lucky enough during my ... Maybe I'll start with the functional part, I'll start with marketing first, and then I'll talk about healthcare. The basic function of marketing has changed significantly over the past 20 years as I've been a marketer, primarily with the advent of digital and social media. It continues now to evolve, as we think about personalized marketing and AI, and what that's going to do. I would say the main changes that I've seen over time has been from a very I would say structured, one size fits all, if you think about it like mass media type of marketing in which there was a time in which you had one singular message and one singular way of approaching individuals, and not a lot of channels to reach them. To now, moving to almost a fully personalized marketing experience, where you have the ability with technology today to be able to say, even if you have thousands of targets, how do you understand the fine differences. There's got to be some generalization amongst those targets, but there's also some fine differences in how people consume their information, care about interacting with your brand, and want to be able to either become loyal brand advocates or detractors. How do you understand what those insights are to create an ongoing personalized journey that evolves over time with the individual as their media consumption and interest in whatever product you're selling changes? That's been one of the coolest innovations to think about, as we think about the function. If I look at healthcare, I've been lucky enough to see innovation across a variety of different segments within healthcare. I'd seen the advent of biologics. If we think about innovation from a healthcare point of view, in basically the last 20 years or so, we've seen drugs like Humira, which started the biologic class and has now exploded into one of the largest categories or segments within healthcare. And the significant impact that that has had on millions of patients, and has changed diseases all the way from skin conditions to much more serious autoimmune type of conditions. I've been lucky enough to see innovation on the diagnostic side, in which I've seen the advent of brand new technologies, including things like multi-plexing. Of taking a single sample, and instead of wanting to get one answer, you can get anywhere from 25 to 30 answers of which virus of which disease somebody has. And the impact that that has had not only on just healthcare, but on infectious disease and vaccines in other parts. For me, what has actually kept me so motivated in healthcare for so long is it isn't just an idea. I get to be part of the teams, and it's a cross-functional team that includes everybody from scientists, research and developers, operations, medical affairs, clinical affairs, marketers, salespeople, finance people, and everybody, I'm sure I'm forgetting some functions. It is such a complex effort to bring innovation like this to market and sometimes can take 10 to 15 years, but when it happens you actually see significant change in healthcare. For me, that's the ability to think even 30, 40 years from now, some of the either diagnostics, devices, or drugs that I've helped to bring to market will really have an impact. Either because it continues to improve healthcare or it was the precursor of future innovation that's going to continue to come because we've paved the way for it, so it's really cool. Preena: Absolutely. That's really incredible. And the way you're able to work with people of many different fields and backgrounds, and then learn from them as well is a really incredible experience, and I hope defines a lot of students' careers in the future as well. Natasha: Yeah. I think just to add to that, the one thing to really keep in mind is I love the interdisciplinary approach that a really good college in arts and sciences like Weinberg does. Because for me, that kind of thinking, although I didn't understand it at the time because I was just a student and I had no clue what I was actually going to do, is something that to this day in my career I think back to and I leverage. It's helped to make me successful, especially in a very large matrix cross-functional organization. It's something that, as all of you who are students potentially listening to this and are thinking, "What might I do in the future?" Really leverage the opportunities that you have to do that kind of interdisciplinary type of work because it will make you much stronger in whatever field you decide to do. Preena: Yeah, absolutely. Going off of that, a bit in the other direction, but what is a common misconception about working in the healthcare marketing industry? Natasha: That is a great question. This is maybe a little controversial, but I'm going to say it. I think there is this perception of big, bad pharma and big, bad healthcare. I think it's something that is an understandable point of view and one which requires probably much more dialogue than what we can answer here. But I'll just leave people with this one thought. Which is if you think about most of the major innovations that have come to healthcare over the last 30 years, whether it's drugs to treat high blood pressure or hypertension, or innovations in diagnostics as I mentioned to be able to not just understand what's happening from blood count, but to be able to look at the molecular and cellular level to treat rare diseases and everything in the middle. Much of that innovation, while it is funded and founded in the basic research that happens at academic and other institutions, has really been driven by the industry. Whether it's the pharmaceutical industry, the med device industry, the diagnostic industry. That requires significant investment and significant time. It also requires a very high failure rate. In some cases, if you have 100 compounds or 100 ideas that you're bringing through, less than 1% of them will sometimes make it to market. There is a significant amount of investment that needs to happen. While there's always optimizations that could happen, I always implore people to think about the fact that the drug that your mother or father is taking today, or that your brother or sister is taking for asthma, didn't exist probably even 20 or 30 years ago because we didn't have the funding and innovation that was coming necessarily maybe from companies that has been pushing that forward. While there is a lot of discussion to be had about healthcare and the rights to healthcare, I think companies like mine, whether it's my current company or previous company, have played a very important role in really helping to improve overall health and healthcare as we think about the impact on people's lives. I just ask people to be open to the fact that there's always a variety of different vantage points and it's always a great healthy dialogue to have. Preena: Of course, yeah. From what you said, it sounds like it's a bit of a trade-off and it's really important to discover where you fit in within that sphere, and learn how to interpret your work and your path in that direction as well. Just realizing what impact you're making and picturing that longterm. Natasha: Yeah, exactly. Preena: Okay. Then, I was also going to ask you about the student perspective, thinking about students today. How would you recommend students cultivate a personal brand? A lot of times people say networking. How do students network authentically, both online and in-person so that they can find the right opportunities or even the right opportunities can find them? Natasha: Yeah, I think it's a really great question. I very much will reiterate the importance of networking because I think that's foundational and fundamental to everything that we do today. In fact, many of you who got into very competitive colleges probably had to figure that out as you were even thinking about how to get into the school that you're in today. That thought process needs to continue as you think about getting your first job, or maybe you're getting your next pre-professional school that you're focused on. I would take that networking to the next step to say I think some of the most effective networking has two really good components. I find this, because I have a lot of people who maybe reach out to me, either through my network or because they're looking for learning about marketing or healthcare, or other topics that maybe I've had some experience with. The first of those two things is really having a genuine brand, and one in which you really own and feel passionate about. The most interesting and coolest networking that I do, even with students today, are the ones in which people are very purposeful about what they are interested in, what they care about, what their brand is. It's probably hard to even think about me as a college student, what is my brand? But you have a brand. You may not know it yet, but you definitely have and can develop a brand. That brand should be whatever you feel truly passionate and genuinely interested in, because that will only I would say help you have much more successful networking and much more genuine connections with the people that you are trying to connect with. Even if that individual maybe doesn't understand or isn't that maybe close to the topic, you'd be shocked how just that genuine authenticity is going to help drive really stronger connections in networking that are going to help both you, as well as the network that you're creating, as you think about the fact that one day you're going to have a network and you're going to want to be able to pay it forward to students the way maybe people are helping you with your decisions and career today. The second one as you think about networking is a lot of times, networking and finding a good fit, whether it's a company or your next pre-professional program, or what you even want to do, is based on having a shared purpose with whoever you're networking with or whatever that institution is. I find the people who come and are most prepared for interviews, in addition to feeling very genuine and knowing what their brand is, are the people who are very clear on what my purpose, either as an institution is, or whatever group I'm part of. They understand that and it is very much akin to who they are, what they're looking for, what makes them passionate. That sense of shared purpose in networking I think is another way in which you can more successfully think about how do you take your decisions or whatever you're going to do next in your career path and be more successful in terms of what you want to do. Then the last thing I would say is don't feel super ... I know everybody's pressured to feel like they know exactly what they want to do and I understand that. I'm sure many of the people who are listening to this are very high performing, have always been very successful in life, have known exactly what they want to do. But there's a lot of benefit to maybe giving yourself the luxury of knowing you have a very long marathon ahead of you, as you think about the decision making in your career choices that you're going to make. If there's ever a time to be open to it, it's probably earlier in your career when you're maybe more willing to not only take some risks, but also be true to what you actually think will be interesting to you over a longterm career. Don't be afraid if it's not going to be a straight line. It might be a really curvy, cool path. At the time, it might feel a little discouraging, but don't be discouraged. Because I would argue, if I look back, some of my coolest decisions were the ones in which it wasn't this straight line, very clear path of what I wanted to do. But rather, I was either more open because of external circumstances or internal motivation to being a little bit more flexible and not so purposeful, and everything must be this in this timeframe. I think if you have some openness to that, it will really help you and probably put a lot less pressure on you as you're thinking about your career. Preena: Right. Yeah, that's really great advice. In terms of winding paths, switching over to your career and more of your day-to-day role, what would say is a challenge or challenges that you often find or encounter in your day-to-day role and how do you approach those? Natasha: That's a good question. My challenges in my day-to-day role. I'm fortunate in which I lead a functional team, so I have the benefit of having an amazing team that I work with every day across a variety of brands and products, across a very diverse portfolio. I've been lucky enough to do that at this current company, which is GE Healthcare, and the previous company I was at which is Abbott. Many times, if I think about the biggest challenges in my day-to-day, it really is around I would say three big areas. The first one is when you are such a large matrix company that is so dependent on your other functional teams, to ensure that you are all very clear on what the goal is, what you're all trying to accomplish, and that you're all rowing in the same direction, and have shared purpose and goals. Often times in our day-to-day, even in companies where you think everybody's on the same team, you can often find that there's actually sometimes a bit of misalignment or competing priorities. Sometimes that's because we're different functions or groups, sometimes it's because we're different segments. Sometimes it's just because we don't understand that shared goal. It's keeping everybody aligned to the mission, strategy, and vision. I would say as marketers actually, I feel like we are big drivers of that in an organization. It's something I always feel very responsible for and want to help my team feel very responsible for. That's the first one. The second one is we work in a very complex landscape. We're highly regulated here in healthcare. We want to do the right thing. Actually, I always tell people I'm so glad that we're highly regulated because the decisions we make actually impact life or death. It's actually for all the right reasons that we have very strict regulatory and approval processes, and then ongoing monitoring of all of our activities from our quality processes to our commercial processes and everything in between. But that can bring a lot of complexity. You've got to navigate a lot of sometimes tough legal and compliance discussions. But at the end of the day, the way we navigate them successfully as a team is really by reminding ourselves that the reason these regulations exist is to keep patients, our own family members who are consuming healthcare every day safe. We're able to do that. I feel we, despite sometimes difficult discussions, always get to the best answer in doing what's right for the patient and what's right for healthcare. Then the third thing, which is I think sometimes hard, is we all come to work every day because we actually care about healthcare and saving lives. That's sometimes really hard to remember when you get stuck in your day-to-day. You can be at a tough meeting, or a really hard strategy review, or a really hard finance review, or maybe you're missing your number in this sales goal. But at the end of the day, those hard days are really worth it because of what ultimately we're bringing to patients all over the globe. Again, there are these challenges, but over a long career I've been able to figure out how to successfully navigate them. So that I feel that even the challenges motivate me to come to work, and figure it out, and be better tomorrow. Better today and tomorrow than I was yesterday and in the past. I try to motivate my teams to think about that in the same way. Preena: Absolutely. Oh, yeah, that was very insightful. I think a lot of these can be applied to any fields, because a lot of times, in healthcare specifically, there is definitely life and death impacts. Then in other fields, people can have those same hard conversations and still need to have that resilience and build up that resilience to come back from that. Natasha: Very true. Very, very true. Probably very similar, just maybe different categories, but very similar discussions that would happen- Preena: Absolutely. Natasha: ... outside of healthcare, too. Preena: Yeah. Okay. Well, thank you very much for sharing this with us and thank you for joining us today. That is all the questions I have. We really value your time, and for coming on and speaking to all of our students. Thank you very much. Natasha: Thank you for having me. It was pleasure to talk to you.  

In this episode of the Weinberg in the World podcast, Aimee Resnick '26 interviews Priscilla Vail-Caldwell '85, founder of Vail-Caldwell Projects. Priscilla shares her undergraduate experiences at Northwestern, including impactful classes and internships that shaped her career in the arts. She discusses her current role as an advisor and curator, helping clients build art collections with a focus on research and quality. Aimee: Welcome to the Weinberg in the World Podcast, where we bring you stories of interdisciplinary thinking in today's complex world. My name is Aimee Resnick and I am your student host of the special podcast episode. I'm a senior studying social policy at Northwestern University who plans to pursue public administration in my home state of Colorado. Today, I'm very excited to be speaking with Priscilla Vail-Caldwell, who is the founder of the consulting firm, Vail-Caldwell Projects. Thank you, Priscilla for taking the time to speak with me today. Priscilla: Thank you, Aimee, for having me. Aimee: Of course. To start us off today, we were wondering if you can just tell us a little bit more about your time at Northwestern as an undergraduate in terms of what did you study and what were the impactful experiences you had at Northwestern that led you to your current career? Priscilla: I think one thing to note is that I came to Northwestern following a year of study abroad in France. As a senior, I studied in France, and then I came to Northwestern with an idea that I wanted to be at a big university near a city. Logistics had something to do with actually my choice of university, and I think it had to do with the fact that I had this experience that had really kind of opened my mind up about the world, essentially. There was that, and for some reason I declared an art history major very early on in my time at Northwestern. I think as a freshman, I had already decided that that was what I was going to do. You had asked what was one of the transformative experiences that I had at school, and I was thinking that ironically, in a way, I think it may have been a studio art class that I took because it was very rigorous and I enjoyed it, and I had a lot of respect for the other students in the class who I thought were gifted than I was. And I then realized that that wasn't really what I should be doing, but I still wanted to be involved in the arts, and I wanted to be involved in art history and working with objects. I always enjoyed those big introductory courses, sort of identifying paintings, and it seemed like a game to me, really. And I enjoyed that. And then frankly, learning about history through the lens of art. That was always something that kind of compelled me. I think another thing that I did while I was on campus, and I do think this is something that big universities offer, especially ones like Northwestern that are near a city like Chicago, are the opportunities to work in different situations outside of the university campus. I always worked, while I was at Northwestern, I waitressed, I did all sorts of things in order to earn extra money, and I found a job at a gallery downtown in Chicago called Frumkin & Struve. It's no longer in existence, but at the time, it was one of the big galleries downtown. And I worked there every Saturday. And then I had time in my schedule during the week, and I would work there usually one day during the week as well. And Bill and Debbie Struve were the principals of the gallery, and they gave me a lot... I mean, for a college student, they gave me a lot of responsibility, and they really brought me into the fold in a sense. So, I was included in all sorts of things, and the dinners for the artists, and I got to meet a lot of the artists that they were working with. And it was exciting and engaging, and I thought that that seemed like the kind of life I wanted to lead. I enjoyed the interaction with the artists primarily. Aimee: Oh, I totally empathize with your studio art experience, I'm taking painting right now, and there are some incredible painters in that class. But I also wanted to just say, I think that your experience having a really meaningful internship in Chicago is a good reminder to students to look outside the Northwestern bubble for opportunities as they're going through school. And I was wondering if you could tell us a little bit more about what you do at Vail-Caldwell Projects now that you're in New York. Priscilla: Well, I'm an advisor and a curator, and I've had my own advisory business now for the last... I think it's been about eight years. I've always been in the professional... I've always been in the commercial art world, but in this iteration, I advise private people who are building collections on acquiring works of art for the collection. We're building things oftentimes from the ground up. Oftentimes, I will start working on a project with somebody and there will be nothing essentially, and we will work on that together and build something that is meaningful and very specific in every single case with every client that I work with. All my projects are very, very different. There are clients that I work with who buy only the work of one artist. There are clients that I work with who focus very specifically on certain kinds of movements in, for instance, the California Light and Space Movement. There are people who are interested in collecting works by female artists. It all ends up having very different kinds of focuses. Each one of the projects allows me to apply my research skills and learn a lot alongside whoever it is that I'm advising, oftentimes about different aspects of the art world. I see what I do, as always, very research-based and obviously sort of a search for quality and also to include different voices in any kind of project that I work on. I also have a very strong background in modern American painting. I have this kind of hybrid experience where I oftentimes advise people on the purchase of work by contemporary and emerging artists, but I have a strong background in historic American painting. Many of my curatorial projects have been focused on the works of some of the seminal painters of the 20th century. I've done a series of exhibitions at Paul Kasmin Gallery on the work of Stuart Davis. I worked with Kasmin on a number of projects. Another one was a exhibition of sculptures by Elie Nadelman, who is artist who came to the United States from Europe and is considered part of the canon of modern American painting or sculpture, really. He's not a painter, he is a sculptor. I've also done projects with smaller galleries where I've curated relevant shows of young, relatively unknown artists. And that's always fun. I enjoy doing that. That's really a wonderful way for me to dive in and learn about what's going on out there amongst a group of recent graduates. So that's always exciting and I enjoy that kind of work very, very much. And currently, I think one of the things that I've just started working on is a collaboration with a gallery in London called Pi Artworks and an artist who they represent, whose name is Jyll Bradley. So I also advise the estate of Stuart Davis. Aimee: Yes, it does. And I have a related question, which is that you mentioned having worked with a lot of different genres and periods and different artists in this realm of art history. And while you were going through your education in your early career, was there a certain artist or movement that was particularly influential or touching to you? Priscilla: I'm going to answer that question by giving you a little bit more of my background. I left Northwestern, I moved to New York, and I took a job at a small gallery. And that year of working there were like three people on staff. That was an experience that taught me that I wanted to go back to school and learn to become more expert on something. I wasn't sure exactly what that was going to be, but I needed more skills actually in order to have the sort of job in the art world that I envisioned. I was accepted at Williams, which a small... Everybody's always confused because it's a college, but it has two graduate programs, and one of them is an art history program that's associated with the Clark Art Institute. I was one of 12 students in that following year, entering in to a two-year program. I had the good fortune of... Linda Nochlin was the visiting professor at the time who, if you're not familiar with Linda Nochlin, she was, she died a few years ago, one of the great feminist revisionist art historians of her time. And so studying with Linda, I began to look into the histories of certain artists like Eva Hesse and Jackie Winsor. Eva Hesse, of course, has been dead for many, many years. Jackie Winsor just died recently. At that moment in time, and I'm still very moved by the work and very interested in it, but I was very much focused on the work of minimalist and post-minimalist female sculptors to be extremely specific. That experience studying with Linda and looking into the histories of these women and the difficulties that they faced in a world that discriminates against women was eye-opening for me. And it's informed everything that I've probably done since. Aimee: Well, that's very interesting. And I think it's fascinating how some of these formative pieces of art really brought your eye into the future and your current work. And I know at the Block Museum on campus, we've had several exhibits that kind of follow in line with the types of art that you've just described in terms of the revisionist view of art history, the modernism with their Arabic art exhibit not too long ago. And I'm going to transition us to that because you're currently a member of the Block Museum Advisory Committee, and I just want to hear more about the work that you do there and then how you use that as a way to bring volunteerism and philanthropy into your professional career. Priscilla: I have always felt that volunteering my time to certain organizations in the art world is as important as the work that I do professionally. The idea of giving back, which I think frankly is something that either is kind of... For me, it's something that was ingrained in me as a young person. I try to only align myself with organizations whose missions I agree with. And that kind of mission usually includes a sort of mentorship for young artists so that there's a teaching element, which I think is really important. And also this sense of inclusion and diversity in institutions at every level. It's not just the artists that you're showing, but also in integration into the organization itself so that it represents the world in a sense. I mean, that's kind of big, but I think you get the gist of what I'm saying. I sit on the advisory board, and I mean, I think that I help in a number of different ways, but I have a feeling that my experience in the commercial art world and my interaction with lots of different artists and different galleries helps the director and the curatorial department in different ways. I can shed some insight sometimes that is useful. And of course, there are other people on the advisory board, not just me, who have similar experiences. My colleague Steve Henry, who is a classmate of mine, is one of the directors, one of the partners, not directors at Paula Cooper Gallery here in New York, so he sits on the advisory board with me as well. I think Lisa has been very wise in the way that she's chosen the members of her board, where we all contribute important things in different ways. Aimee: Absolutely. And I'm curious, outside of the Block, what other organizations do you volunteer your time to? Priscilla: Right now, the Block is my focus, but I was for a long time on the board of an organization here in New York. It's actually on Long Island City called Sculpture Center, which is a Kunsthalle and a place that essentially acts as an exhibition space oftentimes for artists who live outside the United States to have their first museum exhibition here in the US. It's a place of discovery, I think for a lot of people. It's a place that is very research-based, and they have a very knowledgeable curatorial staff that is very involved in the international art world. They do that. And then they also do a very, what I think is a really important annual exhibition that is an open call to artists that is directed at younger emerging artists, again, who haven't exhibited in an institutional space. And there are funds provided and mentorship provided. And it's a kind of learning lab for a group of artists who then create a group show. There's also a curator who's hired from outside who comes up with a theme for the show, and then they work together to put on these annual exhibitions. And they're amazing shows, and they do great work, and it's a very rich environment. Aimee: Next time I'm in New York, I'd love to come see the gallery. That is so interesting. Priscilla: It's a beautiful space. It's a beautiful, beautiful space in Long Island City. I would be happy to take you there, so let's do that. Aimee: Thank you. Priscilla: Yeah. Aimee: I think we're going to pivot a little bit from your specific career more to the field of art history on the whole, and a big part of being in art history is curating relationships with your clients, which you mentioned previously. What is your advice for students who are looking to foster quick relationships with other people, be it interviewers, co-workers, anyone in the professional world that they need to have a really strong bond with? Priscilla: Well, I will say that when... I did a lot of research on people before I meet them, so that at least I understand what it is that they do, what some of their interests might be. I feel like... I mean, in any case, in any field, if you're going into an interview, if you're meeting somebody for the first time, if it's an important engagement of any sort, it's really good to know who it is, who you're talking to. I think first of all, I would say do your research and figure out, find some interesting things to talk about that will interest the person who you are meeting with. And also will give them a sense that you actually know who they are. I think that's always... That's just flattering for one thing, and it also makes you look like you've paid attention. I used to take every opportunity to go out and do things, and I mean, I go to a lot of openings. I get myself into situations where I will meet people. I think that it can be uncomfortable. You might not know anybody where you're going. You could feel sort of nervous and shy, but I think you have to push yourself to be in situations where you might not feel comfortable, but something will come out of it almost inevitably, and you'll walk away knowing somebody who you didn't know before, and you never know where that's going to lead you. I'm a big believer in that, and I sort of feel like I have two personas. I have the person who doesn't like to do those sorts of things, and then I have the person who has to get up in the morning and go to work and for whom it's a requirement. I think those are two bits of advice that I would have. I mean, for students at Northwestern, of course, if they're looking to create networks for themselves, I mean, they have one, right? I mean, you all have an amazing network through the university, and you have professors who want to support and help you. Again, even though I think sometimes it's difficult to push yourself to go in and talk to your professors, they are there for that reason and they want to support the student body and see them be successful and help you to find things outside of the university that will engage you and also perhaps end up being a path towards a career. I don't know if all of that necessarily answers your question, but you've got... I think sometimes you wake up in the morning and you think that you don't have the tools at your fingertips, but you do and you just have to press the button. Aimee: That's good advice. I think a lot of times students at Northwestern are too timid to take advantage of many of those resources. That's really good advice. I have a little bit of background for this last question, which is that I, myself, was an artist history major for two years, dropping the major because I realized I was never going to get a job in art history because I don't necessarily have a family background or the connections to leverage to get a job in art history. And I was just curious, understanding that art history enrollment is rapidly declining. The cover story of the Nation magazine in early April was about how art history enrollment is declining. What advice would you offer to people who might not traditionally undertake a career in art history who are interested in becoming art historians or people in the art world? Priscilla: I think that oftentimes when people approach the idea of being an art historian or being in the art world, that they don't think broadly enough about all of the different things that happen in the art world. Of course, the glamorous jobs are to be a curator at a museum and to be a director or a principal at a gallery. And frankly, not everybody... I mean, as far as gallery work is concerned, really... I mean, there's curation going on, but it's sales primarily. So that might not be for everybody for one thing. Sales is not exactly the job that everybody wants to have. But what I've been thinking about a lot recently, and certainly a lot of the people in the art world who I rely very, very heavily on and whose expertise is impressive are there are registrarial departments at galleries and museums. Those are people who work with the objects and who have to deal with whether it's insurance or packing or moving objects from one country to another. And all of these things, while it may sound less glamorous, are still very interesting and complicated. And so those are jobs, I think that certainly registrarial departments, we depend on them. They're extremely important. And they have their own networks as well, by the way. There's also art restoration and working directly with objects, which is an interesting kind of combination of the scientific and the art historical. Especially for people who are interested in the sciences, there's an application for that in the art world. And there's a lot of ways of... There's all sorts of things that happen like carbon dating and various different X-ray techniques and all sorts of things that help to say define an object isn't really what I mean. But you have to understand organic chemistry in order to be a painting conservator. I think that we should think maybe differently about the art world a little bit than we do sometimes. And art history will inform all of those things. I mean, all of those people who are working in those different departments need to understand art history. They probably wouldn't even be doing that work unless they did. But you can come at it from a different angle. And I think that that's something that should probably be more emphasized. We need more art conservators out there. We really do. And there are a lot of objects to work on. Aimee: Definitely. Definitely. And I have one more follow-up question on that, which is my worst job I ever worked was at the American Museum of Western Art. I love the museum. I think it's a beautiful museum. I love pictures of cowboys, my favorite genre, but at the same time, it was just scanning documents all day as an unpaid internship. And I think that finances are often a really big barrier to entry for people in art history, given the precedence of unpaid internships, years long fellowships where you're not compensated. I'm just going to narrow in on my question, which is what advice would you give to people from non-traditional backgrounds who want to pursue a job in art history at all? Priscilla: Well, a lot of graduate programs now are fully funded, so that might be something to explore a little bit. I know that for instance, Williams, there are a lot of... I don't know that every single one of them, but many of those students are fully funded and also receive help with living expenses, health insurance, all of their expenses are accounted for. That isn't exactly what you're asking me. But I do think that it's good to... If art history is something that you're serious about, and frankly, if something you're serious about an advanced degree is something to consider, there are programs that will essentially fully fund you to study. So that's one potential way. The art world's a little hard actually in terms of entry-level jobs, and people aren't really paid a living wage. And I would like to know a way around that, too. It's a funny thing. It does prevent a lot of people who are gifted and able and should have access to the field, it probably prevents them from entering the field and that's our loss really. Aimee: I totally agree. And hopefully, we'll see some change in that arena during our lifetimes. Priscilla: I hope so. Yeah. I wish I had a better answer to your question, but also I think that when people go in for interviews, sometimes you are hesitant to be realistic about what you need. And I do think that there's no harm in being forthright about that. That's just a practicality, and you should expect it. Aimee: Yes, self-advocacy is very important. And I think that leads us to our very last question. This is our closeout question we ask every interviewee, which is what advice would you give to a senior in college who is about to graduate? From any field, from any major, what advice do you have for young people in this transitional moment? Priscilla: Well, try not to be discouraged. The world is in upheaval right now, but it won't remain that way. Or I think that we hope that it won't, and we've got to believe that it won't. And that it's funny. This is a kind of big question right now, Aimee. Also, don't close yourself off to opportunities that may not fit exactly into the vision of what you have for yourself. I mean, we do meander sometimes, and I think that it's actually important to because you learn a lot about yourself when you sort of take a fork in the road that you didn't expect that you might. I guess proceed without fear if it's possible, and have confidence in yourself. I mean, anybody who's graduating from Northwestern has done an amazing... They're capable. You're able. You can go out there and get it done. So yeah, I guess we all just remain... I know it sounds sort of like trite, but be positive. Aimee: Absolutely. That's all we can do. All we can do is control our own- Priscilla: Yeah. And fight and stand up for the things that you believe in. Give me the opportunity. Say it, say it out loud. Say what you mean. Don't be scared that somebody might disagree with you. Aimee: Absolutely. It's tough to keep that in mind with the current challenges the university is facing, but that is very good advice. I just want to say in general, thank you so much for your great advice and for chatting with us today. I think this podcast will be so helpful to many students who are interested in either going into art history or just looking at the state of the world right now. So thank you for being with us. Priscilla: Aimee, thank you. You're a very impressive young woman, I appreciate the invitation and it was fun talking to you. Aimee: Thank you. So to all of our listeners, thank you for listening to this special episode of the Weinberg in the World Podcast. We hope you have a great day and go Cats.

Brian Teague - Chicago Sky ACC Issues Dave Eanet Northwestern Stadium Share this podcast on your social media & please give us a 5-star rating if you enjoyed the podcast! We ask YOU to help Big Sports Radio & IlliniGuys Sports Spectacular grow on social media by following us on all our social media and engaging with the content posted. Every like, love, comment & share help Big Sports Radio and IlliniGuys Sports Spectacular reach more people and establish our position as the leader in entertaining, fast-paced, non-political sports programming. Don't miss our college sports focused podcasts: IlliniGuys Sports Spectacular I on the Illini Mike Cagley's Heat Checks & Hail Marys Thanks for listening!

The Chicago Bears have paused plans for a downtown stadium to focus instead on Arlington Heights. Crain's commercial real estate reporter Danny Ecker discusses with host Amy Guth.Plus: Jenner & Block lawyer's security clearance pulled by Trump administration; Kraft Heinz plans $3 billion plant upgrades despite lower profit outlook; another United hub hit by air traffic outage; and with federal action looming, Northwestern hits the gas on lobbying efforts.

This is the sixth and final installment of the 2025 NHCA Updates in Music Audiology Workshop recap. In this episode, we'll listen to Benj Kanters' lecture "Tools For Teaching Awareness From the Intersection of Music, Audio and Audiology". Whether you call it the caboose, anchor, closer, wrap-up, coda, or ultimate, Benj's talk was the last of a long day of lectures and panel discussions circling the larger topic of Music Audiology, and we could not have imagined a better way to close out the workshop. Note that the content has been edited slightly for the audio-only format, and these lecture recordings are not eligible for CEUs. If you want the full educational experience, we invite you to seek out the National Hearing Conservation Association and our annual conferences. Benj Kanters (BS/MM Northwestern University) is associate professor emeritus of audio, Columbia College Chicago, where he was on the faculty of the Audio Arts and Acoustics department from 1993 to 2022. He directed the Audio Design and Production major, teaching audio physics and recording/production at all levels of the curriculum. After studying hearing physiology as part of his master's degree at Northwestern, he developed the course Studies in Hearing in 2002, teaching physiology, disorders and conservation as a department core Requirement. Prior to Columbia, Benj spent twenty years in the Chicago music scene. He was partner and sound engineer at the concert-club Amazingrace, and later partner and chief managing engineer of Studiomedia Recording in Evanston. In 2007, he founded Heartomorrow and The Hearing Conservation Workshop, visiting universities and professional organizations to teach his unique flavor of hearing awareness to students and professionals in audio, music and the hearing sciences. To date, he has presented over 100 workshops in the US, Mexico and Europe and in recognition of his work received the Safe in Sound award in 2014.

-Sean and Sip chatted with Matt Rhule on Monday…there was a lot of conversation about special teams, but what did you learn about Nebraska's potential interest of CharMar Brown, who ended up at Miami?-Nebraska apparently knows who their punter will be coming in but we won't know until June…what's your view of the placekicking situation right now though?-Sean pointed out that Leighton Burbach of Norfolk Catholic is headed to Northwestern, the first player in decades to leave the state for Evanston…was he on Nebraska's radar at all or not?Show sponsored by NEBCOAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Crain's residential real estate reporter Dennis Rodkin talks with host Amy Guth about news from the local housing market, including insights form the latest Chicago-area new home sales data and not one but two properties with ties to the new pope.Plus: Pritzker budget team slashes state's revenue forecast by $536 million, City panel OKs subsidy for 400-unit office-to-apartment conversion, Northwestern facing federal civil rights investigation over alleged discrimination and United Center owners revamping arena's upper suites.

The National Institutes of Health is the largest public funder of biomedical research in the world, but under the Trump administration, NIH is freezing funding to several universities, including Northwestern. One of the projects being delayed is cutting-edge research on ovarian and pancreatic cancer. Reset learns more about the effect of this freeze on patients and early career scientists with Josh Leonard, professor of chemical and biological engineering at Northwestern University. For a full archive of Reset interviews, head over to wbez.org/reset.

-Norfolk Catholic o-lineman Leighton Burbach committed to Northwestern over the weekend, the first player from the state to commit to the Wildcats in decades-Burbach is among at least 10 in-state players who for sure won't be coming to Nebraska; 12 current players in the 2026 class hold offers from Power 4 schoolsShow sponsored by SANDHILLS GLOBALAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== Learn the business and management skills you need by enrolling in the University of Tennessee Physician Executive MBA program at nonclinicalphysicians.com/physicianmba. Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== Dr. Ati Hakimi, a Northwestern-trained family physician with additional geriatrics training from Rush University Medical Center and an executive healthcare MBA from UC Irvine, joins John to illuminate the transformative potential of Direct Primary Care (DPC) as a pathway back to fulfilling, independent medical practice. After experiencing burnout from corporate medicine's unattainable metrics and assembly-line patient loads, Dr. Hakimi discovered DPC—a membership-based model where patients pay a flat monthly fee (around $150) for unlimited access to their physician through calls, texts, and visits. John and Dr. Hakimi discuss how this approach eliminates insurance bureaucracy while delivering remarkable benefits: deeply discounted labs, imaging, and medications; unhurried appointments; and the freedom to practice medicine according to one's own values rather than corporate metrics. With only 150 patients (compared to thousands in traditional practice), Dr. Hakimi operates with minimal overhead, no staff, and complete autonomy—creating a practice that not only better serves her "members" (she doesn't call them patients because "they're not sick") but has restored her professional joy. Their candid conversation reveals how physicians at breaking points with corporate medicine might find salvation in this model without needing to abandon clinical practice or compromise their incomes. You'll find links mentioned in the episode at  nonclinicalphysicians.com/awesome-direct-primary-care/

In this episode, John A. Rogers, PhD, a pioneering material scientist and founder of stretchable bioelectronics, discusses his career and groundbreaking work on wireless health monitoring systems, which are now being used in low-and-middle income countries to improve maternal and fetal health and surgical recovery.   00:00 Introduction to the Explore Global Health Podcast 00:21 Meet Dr. John A. Rogers: Pioneer in Stretchable Bioelectronics 02:34 The Journey to Northwestern and the Birth of Sibel Health 05:07 From Childhood to Academia: Dr. Rogers' Early Influences 06:51 Academic Pursuits and the Path to Bell Labs 13:12 Breakthroughs in Flexible Electronics at University of Illinois 16:12 Translational Biomedical Engineering at Northwestern 18:51 Global Health Initiatives and Collaborations 27:05 Advice for Aspiring Global Health Professionals 28:09 Conclusion and Farewell  

Miami Northwestern's Leon Strawder joins Larry Blustein as they talk about his high school football play and if he's gotten any offers from D1 Colleges

With Brandon Johnson halfway through his first term in office, Crain's politics reporter Justin Laurence talks with host Amy Guth about his recent conversation with the mayor reflecting on the last two years.Plus: Stellantis yanks plans for Belvidere battery plant and parts hub; a Texas investor picks up Arlington Heights shopping center; Northwestern medical school cuts and consolidates research centers, including one focused on equity; and largest U.S. grid operator warns extreme heat risks summer power shortages.

What effects has the Trump administration had on Northwestern? On this special episode of The Weekly, The Daily dives deep into the past few months of news since Trump was elected into office with Managing Editor Jerry Wu. Read the full article here: https://dailynorthwestern.com/2025/05/12/audio/the-weekly-the-trump-administration-and-northwestern-all-the-news-in-one-place/

Anita Cline-Cole is an alum and current leader at the University of Northwestern.  Her story inspires us--even in the midst of grief--to love God and trust what he has in store for us.  

April: Welcome to the Weinberg in the World Podcast where we bring stories of interdisciplinary thinking in today's complex world. My name is April and I'm your student host of this special episode of the podcast. I'm a second year student studying physics and integrated science, and I'm looking forward to learning more about our guest's career. Today, I'm excited to be speaking with Rachel Pike who graduated from Northwestern in 2006 and is now COO at Modern Treasury. Thank you, Rachel, for taking the time to speak with me today. Rachel: Nice to be here. Nice to meet you April. April: You too. To start us off today, I was wondering if you could tell us more about your time at Northwestern as an undergrad. What did you study? And how did you get to your current career path? Rachel: Oh, man, two different parts. The easy part is to say what I did at Northwestern, so I majored in chemistry, physical chemistry specifically. I had a minor in African studies through the center or program for African Studies. And I did my honors chemistry work with Franz Geiger, Professor Franz Geiger in the chemistry department. So that's sort of the what. My major extracurricular was Fusion Dance Company. That's where I spent a lot of my time. How I went from there to here is such a circuitous, crazy path. It is not direct. I left Northwestern and did a Gates scholarship, I did a PhD in chemistry at Cambridge. Loved it, but I was not meant to be a professor. You could ask John Pyle or Franz Geiger, both of whom advised me. It's just it takes a very certain wonderful mindset, but it's not me, to be a lifelong academic. So I left academics and got an amazing role in venture capital and got to learn all about startups from the investing side. Did that for just over four years. And in my last couple years, started getting really close to one of our companies and operating with them and ended up launching products for them and got the bug. Realized that that was a better calling, a better match for me, which we can talk more about what I mean by that. And moved into operating, so then I worked for a health tech healthcare software company and then I moved here into FinTech. So it sort of couldn't be more random, but also each step made sense only as one step. It's just as a sum, they lead you very far from where you were. Not normal in any sense, but in the end I just don't think anything is normal. All paths turn out to be good as you make these accumulation of small decisions. April: Yeah, okay. What are the most challenging and rewarding aspects of your current job then? Rachel: There's a lot. The hardest thing in a startup, there's so many things that are hard about startups, growing startups, but prioritization and focus is one of the hardest things. And you have to actually prioritize not doing things you want to do, which is very antithetical to what it's like to be a driven, hungry person and be in a company of 200 driven, hungry people. You want to do everything that you see that seems like a big opportunity and a challenge that we need to fix, but you can't. There just literally is not enough time in the day and there's opportunity cost to lack of focus. So I think the hardest thing is, the phrase I always use with my teams is you have to let that fire burn. You just have to pick things that you know are broken that you're not going to fix, that it's not the highest priority thing to fix or things you want to work on that you know we just can't go work on that thing right now, we have to work on this other thing. So it's very counterintuitive and I would say that's the hardest thing to learn when you enter startups, how to get through that kind of mindset. April: Yeah, prioritization is pretty hard when there's so many options. Rachel: Yeah. Yeah, when there's so many options and when you're hungry and you feel like a small startup is always up against big Goliaths, so there's a billion things you can do to go after companies that are bigger. So I would say that's the hardest in terms of not the content of what we do is the wrong word, but what Modern Treasury builds and how we bring it and sell it in the market and how we run the company. Letting fires burn and ruthless prioritization is the most unnatural part of working for a startup, I would say. On the interpersonal part, so not what we do, but how we do it, like in every stage of life and everywhere I've been, the hardest part of anything is getting really good at giving and receiving feedback. And that is a lifelong, you have to dedicate your life to it and using that to make decisions with people. April: Could you talk a little bit more about what your company does and what your role is? Rachel: Yeah, sure. So I'm chief operating officer of Modern Treasury. Modern Treasury is a payment operations software platform. So we help companies of all sizes, from other startups to huge big public companies, manage their money movement. And it sort of sounds like a back office thing, but really, we actually mostly get bought by product and engineering teams. And those product and engineering teams that are our customers want to do payment stuff. They want to build a digital wallet or embed payments in their application. Or we also serve non-tech companies, so you're buying a house and you need to pay the real estate agent or you're buying a house and you have to go through the title and escrow process on that home purchase. A lot of money moves around in those businesses. In fact, it's core to all of those products to move and manage and track money. So we build the software for that. Complex payment systems get built on top of us and complex payment products. We have an engineering database product called Ledgers, which is how you, with high performance and perfect fidelity, track balances, which is a really hard computer science problem, although it seems that it should be easy. It's a very hard computer science problem. And then you can imagine that as we grow and have more and more data and understanding, we're building more and more AI into our platform, so teams can run in a safe way with AI helping them. So anyway, yeah, it's a complicated thing that we do, but we help companies move and manage their money movement. April: Okay, cool. So how well did college prepare you for this career, do you think? Or what was the most important skill that you learned from college? Rachel: There's so many things that you learn in college as you sort of separate from home life and become your own person. I think there's soft skills and hard skills. I obviously don't use the traditional academic knowledge that I got in my undergrad and graduate experiences in chemistry, not a chemist anymore. But I don't think there's anything that can replace scientific training in how to think and pursue questions and how to separate how to go through a research process and understand and also understand the limits of your knowledge. That is a very profound experience the more advanced you get in science. I didn't even get that advanced. But in understanding the boundaries of what the community of scientists knows and what personally and how to ask questions, build a hypothesis, and go again. And I know that the hypothesis process is something you learn in like second grade or fourth grade or whatever, you go to school, but truly, that process is very hard, like holding yourself to a standard of making a rigorous, very thought out hypothesis and understanding what would prove or disprove that. In a scientific setting in a lab, sometimes it's a little easier to go through that process. Hey, if this experiment works, I'll see X. In a business environment, that's actually very hard. How do you measure? Is that metric actually counting that? What else is getting conflated into these signals and systems? And then almost everything, unless it's something like website clicks or latency or something that's directly measurable, almost all the signal that you get is mediated through people. So not only do you have to go through this process of trying to constantly get to truth, everything that you're trying to pursue is going through people. So I would say academically, that's the longest lasting impression for me. My team gets annoyed because I say things like rate-limiting step all the time, which is a chemistry phrase. So it taught me how to think. I think another very impactful part of my college, two other very impactful parts of my college experience, Fusion was just getting started, I was one of the people that helped get it started. And starting a club that is, very proud to say it's long-standing and I could never audition and get accepted today, is a lot like starting any organization. How do you run things? What is governance like? How do you navigate people? What are the expectations? How do you communicate that? How do you do things excellently? Starting and building a club is very similar to starting and building an organization, it's just we get a lot more complicated with time. So I learned a lot in that process and running rehearsals and putting on a show and what it's like to run an audition process. I have very fond memories of that. And lastly, I would say is I studied abroad for all of junior year. And I don't know if this is true, but someone along the way of me, because chemistry has so many sequential requirements, and it was very hard for me to figure out how to do those requirements and still be away for a year, someone along the way told me I was the only chemistry major who was ever away for a year then. It's probably not true now. I also don't know if that's true, speaking of rigorous hypotheses, so that's an aside. But the experience of being abroad, I was in Tanzania, was obviously profoundly eye-opening. And being in multiple cultural contexts, not just for travel, but for a long period of time with real life, day-to-day life, it just changed my whole perspective on the world. And then same thing, I lived abroad again for my PhD, so I was abroad on and off again for about like five out of six years. It really changed my perspective on the world, my perspective on people, and I only got that opportunity because of college. April: Yeah, college is a great time to study abroad and do those things. Rachel: Yeah. Yeah. April: [inaudible 00:09:31] possibilities, yeah. Also, it's so interesting to hear that you found Fusion or helped found it because it's such a big thing on campus now. Rachel: It's such a huge thing now. April: [inaudible 00:09:39]. Rachel: Yeah, no. We really grew it, but it was small when we started. We were just in parades and doing small shows, and then we finally started putting shows on in Tech my last two years there. It was very fun, really meaningful experience. April: That's great. Yeah. Rachel: Yeah. April: Then you kind of touched a little bit on this, but could you elaborate more on the biggest adjustment you had to make going from undergrad to industry? Rachel: I actually got this piece of advice when I went from my PhD to venture. I went and had coffee. One of the coolest things about Silicon Valley and the technology community is that it's very open and if you ask people for advice, they're really open to giving it and having conversations like this, but times 10. So one of the coffees I had was with someone who had also had a PhD and moved into venture. And he said something to me that has always stuck with me, which is the biggest adjustment you're going to have to make is the complete lack of rigor in business decisions, which is hysterical, and I don't think fully true, which I'll explain, but it is true, the standards of rigor in academic science are completely different than the standards of rigor in making a business decision. So I always think about that moment of you got to get used to the fact that they make decisions with less information. I think that's only partially true. I think one of the reasons is true is what we talked about, that data is often mediated through people, and so it doesn't feel as rigorous. But actually, the decisions you're making about and with people are just as important. It's just different, and that is a very big adjustment. There is not always right. It's not a test or a thesis or whatever, and that's a big change. There's just making a decision and then owning the consequences of the decision and upside of the decision. But that, it's a huge change. So that's what I would say one of the biggest adjustments that I had to make. On a more practical basis, specifically like Silicon Valley and startups, they're just opportunities, they are roles, sorry, environments with very little management structure. That's the whole point, you're doing something from scratch. There's not someone telling you what to do. That's not true if you go into industry and go to a very big technology company or a bunch of industries I've never been in that are managed in totally different ways. That obviously is like two hops from undergrad. I had a PhD and then I had time in investing. But yeah, working without a lot of oversight, also a big change. April: [inaudible 00:11:58]. The training you get from undergrad to grad school and then going to industry, it's a bit of an adjustment, but yeah. Rachel: Yeah. April: It's an interesting problem, how you would apply your scientific training to the business world. Rachel: Yeah. What do we know and what do we not know, is a question I often try and ask myself. In fact, I was thinking about it late last night about something we're trying to figure out in our business. And it's hard because you sometimes feel like you know things that you don't. It's a trick of the brain. April: Then sort of related, but what are some current trends that you're seeing in the industry or in the area that you work or some of the modern day challenges? Rachel: I would be remiss if I didn't say the most enormous trend in technology right now is AI. So there's sort of no other answer you can give them that, this unbelievable explosion in technical capability and then it's application into all kinds of industries. So I don't know, Modern Treasury has been such an interesting ride. One of the things that is interesting about startups is you really cannot predict the world around you. So this tiny company, we're not tiny anymore, but this company that was tiny, I was the first employee, it was just the four of us, just us chickens in a co-working space, trying to build this payment operations company. And in the interim, COVID happened and we could never work together again until many years later. And then Silicon Valley Bank crashed and there were multiple bank failures all over the country. If that had happened two years earlier, it would've taken our business down. As it happened, it accelerated our business like, oh my god, better lucky than good. Now we're going through an AI transformation. Crypto has gone up and down three times in those six and a half years. It's just wild what happens around you and how that affects the work you do day to day. So I don't know. One thing I would say is things are unpredictable. I have never learned that more than in this particular job I'm in now. April: For sure. Would you say that kind of unpredictability is characteristic of working at a startup versus a larger company or even in academia, for example? Rachel: It's a good question. I'm not sure I'm the right person to answer because I've never worked in a huge company. I've always worked in... Investing is also in the business of startups, so I don't think I'm the right person to answer. I think I have a hypothesis that it affects you less. If you're in a big established company where things don't go, the amplitude of the curve isn't quite the same level, I don't think you necessarily feel it as much. AI is happening to everyone no matter where you work, right? I assume you're all using it every day in your undergraduate environment. So that's universal. I think how it affects your job or what you're using it for is probably different. If you're a computer science undergrad, it's really affecting what your experience is like compared to five years ago. If you're a physical chemistry undergrad like I was, doing some frequency generations two floors below in the basement of Tech, I'm sure it's helping on the research side, but nothing changes the lasers but hands yet, until the AI robots come. So I just think it depends how much the volatility affects your certain area of pursuit. April: That makes sense, yeah. So with all this volatility, how do you approach work-life balance? Rachel: I don't think there is any, in all honesty. My mornings are totally insane between the 27 things I'm trying to do, and I'm always later than I want to be to my first meeting, and that just is what it is. I actually have a four-page document called Working with Rachel and for people to get to know what it's like to work with me when I hire and bring on new teams or new managers, et cetera. And one of the things that's in here is my mornings are insane and I'm always late and I'm totally frazzled and whatever, but I can almost always talk in the afternoons and nights almost any day. You just have to know your rhythm. Exercise is a huge part of my management of work-life balance. So probably started before Fusion, but definitely long, hard dance practices helped me get through undergrad. And at every phase of life I've sort of had a different exercise, deep exercise pursuit and crutch, I would say, to get through the craziness of life. So that's really important for me personally to focus and, I don't know, just get to a different level than the overly intellectual all the time, brainwave level into the body and into the breath. So that's huge. And then more tactically, I'm terrible about always having my phone around, but I do always have my laptop on do not disturb. So when I'm working in my environment, Slack and email are going constantly nonstop, especially Slack. So if I actually want to write or actually want to read or actually want to listen, the pings don't help. But to do my job, I need to be ever present with my teams. So just practically, it's always on do not disturb, and then I pick when I check. So I don't know, that goes from small to big of how I manage and cope with work-life balance, but it's the truth. April: There's some pretty good tips though. Sympathize. Rachel: Do people in Northwestern use Slack? Is that part of an undergrad life or no? April: Some of the clubs use it. I have a couple- Rachel: More texting? April: Yeah, they use GroupMe. Yeah. And then I know a lot of the research labs use Slack. Rachel: Oh, that makes sense. April: Yeah. Rachel: Yeah. But less of the all in every day, all encompassing, et cetera. April: Yeah. Rachel: Yeah. April: Do you think those work-life balance habits were developed during your graduate school years or in college or as you go into industry? Rachel: I don't know about do not disturb because technology has, not technology, but the physical hardware of communication has advanced so much. I'm so old compared to you guys. And when I was an undergrad, Facebook came out when I was a sophomore. So just think about how different of a world it was then. We had really kludgy Hermes email, Hermes email server at Northwestern. So the never ending notification encroach on our life, it existed then. And of course, we texted, but we texted T9. So it's just a different world. So we had it and obviously we all needed to learn how to focus, but not to the extent that it is a challenge for people in college and PhD programs now, I don't think. That's my guess as an outsider. But some things, like exercise, 100%. I think those things get developed earlier on. But once you're in university, it's your decision to continue to pursue them and how much you pursue them and how much they're a part of the rhythm of your life. So that, I would say for sure, I established for myself at Northwestern. April: Was there anything at Northwestern that you wish you had participated in that you didn't? Or the other way around, that you did but you wish you had opted out? Rachel: I wish I'd done dance marathon earlier. I only did it senior year and it was like what an incredible experience. Once you had the experience, then you realize, oh, I should have been doing this the whole time because it's like, I don't know, it's just something you could only do in an all encompassing environment like that. My major regret at Northwestern is actually academic, which is a silly small choice, but I studied French in elementary and high school and I really wanted to learn Spanish as a California person. So I took it in college, but that ate up a lot of quarters of getting my language credit because I was going from scratch. So my regret, and I'm not very good at languages anyway, so it's not like it stuck around, my regret is actually not that I took it, it came from good intentions, but that I used up six possibilities of taking classes in non-chemistry, non-African studies. Just you're spoiled for opportunity in undergrad of going to learn about everything. And it's one of the amazing parts about Northwestern and the way they do the core curriculum, that everyone has to learn a little bit of everything somehow. And that's my biggest regret. I regret not taking a philosophy class or a whatever. I took one world religion class, but should I have taken two. That breadth is the thing that I crave and miss. And by the time you get to PhD, and certainly in the British education system, you specialize earlier, so that opportunity's gone. You can obviously go to lectures and stuff, which I did, but it's not the same as being in a class. So yeah, my biggest I wish I had is I wish I hadn't taken Spanish in that environment and done it some other way and had six quarters to go just do dealer's choice of interesting things in departments I never would've gotten to know. April: Did you have the Weinberg language requirement? Rachel: Yes. April: But you got out of it with French? Rachel: I could have taken I think only one quarter or no, I can't remember how my testing was, sorry. But I could have taken either one quarter or zero quarters of French. But I instead put myself from scratch with Spanish because I've never taken it before. So I don't know, I just think that was good intentions, wrong decision. April: It happens. Rachel: Anyway, yeah, that's my biggest, I don't know, regret is too strong a word, but if I had a magic wand and could do it all over again, I would've taken more general humanities or other types of classes. April: Speaking of classes, what were some of your favorite classes at Northwestern? If you were to- Rachel: Oh my God, do I even remember? April: Yeah. Rachel: The physical chemistry. I don't remember if it's physical chemistry honors class or physical chemistry practicum. It's the last thing you take senior year with real world lab problems. And that class, there were six of us and we were in lab, I don't know, four or five hours twice a week. We were there all the time. It was so hard and so intellectually stimulating. I remember that class extremely well. I remember my world religions class. I don't remember who taught it, but it was the only time I ever studied anything like that. That was interesting. And I remember some of the seminar debates I had with other people. I don't know, those are the two that come to mind. April: Very cool. Now that we're getting towards the end of our time, the last question is if you were to look back on your undergrad, which I suppose we already did a little bit, but what advice would you give, I suppose, other people in your position? Rachel: I have one very specific piece of advice that I give to a lot of undergrads or people early in career, which I can share. And then the other is one that I give all the time now, but I don't know if it's relevant, but I'll share that one too. I'll start with the second one first because it might be less relevant. The one I give now, that is also can be very counterintuitive to people who are working on giving and getting feedback and what it takes to truly manage and motivate teens, is that clarity is more compassionate than kindness. And I don't mean don't be kind because the goal is, of course, to deliver clarity with extreme compassion and care. But it's nerve wracking to tell someone, "You're not meeting expectations for this role," or, "We did not hit our goal as a company and we have to make this really hard decision," or whatever the hard thing is that you have to say. It's harder to say it clearer than to say, "Well, I know you this and what about that, and I'm so sorry and this is hard, blah, blah, blah. But I think maybe the role," and then the person walks away and is like, "I don't know what I heard," and they don't know that they're not meeting expectations. So I would say that took me, it's a lifelong pursuit, I don't think I'm perfect at it yet. No one anywhere in my academic career, undergrad or grad, really taught me that. So that's one. I'm not sure if that's relevant for a sophomore undergrad, but maybe. April: I think so. Rachel: Could be. The advice that I often give to undergrads or very early in career folks, who are either looking for startups or end up whatever. I actually have a call with one this afternoon who's a woman who's a family friend who's thinking about a job change and she's like just wants my advice. I think that one of the unrealistic things that somehow culturally gets imbued in very driven and successful students, like all of the people who get accepted to Northwestern, is that you can have it all in your first job. And that is fucking bullshit. And I think it leads to a huge amount of heartache and angst because it's not true. Now, what you can have is one or two awesome things. So when you're, like you graduated at 21 or 22 or whatever age you are, you have usually no strings attached. You can make incredible broad decisions that you can't make later on and that affords you the opportunity to go do amazing things. But what you can't do is do it all at once in that one first job. So the specific example that I often give is you could pick where you work or what industry you work in or that you make a lot of money, but it is basically impossible to pick all of those things. So if you're a econ undergrad at Northwestern, of which there are many, it's probably pretty hard to work in a mission-driven company, make a 300,000 a year banker undergrad job, and move abroad for that first job as an American, blah, blah. That doesn't exist. If you want to make a lot of money, there are incredible programs with established firms where they really reward you for hard work really early on and that's the trade that that job encompasses. And if that's valuable to you, awesome. But you're probably going to be in one of their major locations and they're unlikely to ship you to Sydney for being 22. If you have the opportunity to go do something extremely mission driven that speaks to you, that's amazing, go do that. But you're probably not necessarily going to pick where or you're not going to be highly compensated. So I often talk to people who are in their early 20s who are like, "But I really want to be in New York, but I really want to work, I want to be in the arts and I want to do this, but I need a lot of money to support this thing." You're like, "You can't have it all." And that's not bad, it's just true. And it's much more compassionate for me to tell you, April, if you want to pursue physics, that's awesome. I was a PhD student. You're not going to make any money in your 20s. April: That's true. Rachel: But you might work at the cutting edge of science in something incredible that super motivates you. That's awesome. So if I could wave a magic wand for undergrads, I would get rid of that angst of that decision making. And the decision can have angst because it can be hard to choose a path, but the you can have it all, I think is a great lie. That's not fair to people in their late teens and early 20s in undergrad. I thought of another one, so I'm going to give you a third, even though you didn't solicit another one. Which is you at the beginning of this you asked about my career, which is kind of all over the place from a traditional perspective. I was in academics and then I went to investing, and then I went to startups. And then in startups, I was in healthcare and I went into payments in FinTech. It's all over the place. Every time I made the jump, everyone around me told me I shouldn't because I was leaving their path. And to be an amazing professor, you stay in academics. So people leaving academics is like, they don't want to give you the advice to do that. Or when you're in investing, the way you stay in it, and particularly in private investing, it's long feedback cycles. You got to stay and practice the craft. So I said, "Hey, I'm an operator at heart. I'm going to go do this thing." Some people encouraged me, but many people said, "Why would you ever do that? Why would you ever leave the job you have? Stay in practice." And then same when I left healthcare and picked a totally new thing. So that's more mid-career advice, which is like it's okay to leave that perfect tracked path and trust your gut. April: Yeah, that's actually really valuable advice, so thank you. Rachel: I hope so. April: Yeah. Thanks for taking the time out of your day to talk with me and to give all this advice to whoever's listening. Rachel: Yeah. It's awesome. Nice to meet you, April. April: Mm-hmm. And thank you for listening to this episode of the Weinberg in the World Podcast. We hope you have a great day and go Cats.  

Jon Dhanawade, Private Equity M&A Partner at Mayer Brown    In this episode of M&A Science, Kison Patel sits down with Jon Dhanawade to unpack how private equity firms structure M&A deals—what works, what doesn't, and how to manage risk every step of the way. Jon brings legal insight from both sides of the table, sharing practical strategies for aligning deal terms with investment objectives, mitigating downside risk, and building strong seller relationships. Whether you're a corporate buyer or a fund-backed operator, this episode will help sharpen your deal judgment and show you what it takes to get complex deals over the finish line.

In this episode, The Daily looks ahead at the postseason of Northwestern women's lacrosse. Read the full article here: https://dailynorthwestern.com/2025/05/08/audio/cats-corner-lacrosse-heads-to-ncaa-tournament-hoping-to-clinch-national-title/

Send us a textDaniella (Danny) Guyette is an emerging talent in collegiate lacrosse, recognized for her agility, composure, and leadership as a goalkeeper for Syracuse University.Originally from Newbury Park, California, Guyette's lacrosse journey began at Newbury Park High School, where she was a standout player. She earned multiple accolades, including three-time All-Marmonte League First Team and All-Ventura County First Team honors. Her senior year was particularly impressive, as she posted a .590 save percentage with 130 saves in just 12 games. She was also named to US Lacrosse's Fab 50 and played in the Adrenaline All-American Senior Game.At Syracuse, Guyette has continued to develop her skills. After missing her freshman season due to injury, she made her collegiate debut in 2024, playing in seven games and recording a 7.63 goals-against average with a .524 save percentage. She made her first career save against Virginia Tech and had a season-high three saves against UAlbany.Guyette's dedication to the sport has been shaped by her admiration for past Syracuse goalies. Growing up, she studied the play styles of standout SU goalkeepers like Asa Goldstock and Delaney Sweitzer, incorporating elements of their game into her own. Now, with Sweitzer's transfer to Northwestern, Guyette is poised to take on a larger role as Syracuse's starting goalie in 2025.Off the field, Guyette is pursuing a degree in forensic science and has been recognized for her academic achievements, earning spots on the ACC Academic Honor Roll and the Athletic Director's Honor Roll.The start to her Syracuse career didn't go exactly as planned as Guyette suffered a knee injury keeping her out the entire year. We talk about the process of overcoming an injury like that both mentally and physically.Her journey from a determined high school athlete to a rising collegiate star serves as an inspiration to young lacrosse players aiming to make their mark at the next level.Enjoy my conversation with outstanding Syracuse goalie Danny Guyette.Support the show

In this episode, Peter Von Panda shares a unique find—an intricately detailed 3D printed replica of Northwestern's Ryan Field, made by Swiftland Replicas. A true piece of nostalgia, this model captures the essence of the old stadium before its billion-dollar renovation. Peter discusses the features of the replica, from the iconic Randy Walker Terrace to the Wildcat statue, and reflects on the importance of commemorating memories before the stadium changes forever. Whether you're an alum or a sports fan, this is a collectible that brings history and college football culture together. ▶ Get this product here: https://www.ebay.com/usr/swiftlandrep... ▶ Get other stadiums here: https://geni.us/9Hnhsbc ---------- LET'S TALK ABOUT LIVING BETTER: ▶ Podcast: https://geni.us/FtGAT4 ▶ My Amazon Store: https://www.amazon.com/shop/petervonp... ---------- IF YOU'D LIKE TO SHOW SOME LOVE: ▶ Buy My Book: https://geni.us/qwbZAE ▶ Become A Channel Member: https://geni.us/AA3Jk ▶ Patreon:   / petervonpanda   ▶ Merch: https://petervonpanda.storenvy.com/ ▶ Free Panda Group: https://panda-research-institute.mn.co FOLLOW MY OTHER SOCIAL MEDIA PLATFORMS: ▶ Instagram:   / petervonpanda   ▶ Facebook:   / petervonpanda  

Dr. Wendy is sharing three toxic relationship habits. We are also talking to Dr. Finkel, author of the bestselling book The All-Or-Nothing Marriage: How the Best Marriages Work—is a professor at Northwestern University, where he has appointments in the psychology department and the Kellogg School of Management. At Northwestern, he also serves as the Morton O. Schapiro Fellow at the Institute for Policy Research and founding co-director of the Center for Enlightened Disagreement. He studies romantic relationships and American politics. In his role as director of Northwestern's Relationships and Motivation Lab (RAMLAB), he has published ~170 scientific papers and is a Guest Essayist for The New York Times. The Economist declared him “one of the leading lights in the realm of relationship psychology.”

 Dr. Finkel, author of the bestselling book The All-Or-Nothing Marriage: How the Best Marriages Work—is a professor at Northwestern University, where he has appointments in the psychology department and the Kellogg School of Management. At Northwestern, he also serves as the Morton O. Schapiro Fellow at the Institute for Policy Research and founding co-director of the Center for Enlightened Disagreement. He studies romantic relationships and American politics. In his role as director of Northwestern's Relationships and Motivation Lab (RAMLAB), he has published ~170 scientific papers and is a Guest Essayist for The New York Times. The Economist declared him “one of the leading lights in the realm of relationship psychology.” Also he has an amazing podcast. Check out Love Factually

David Gold, editor emeritus of InsideNU, joins me to preview Northwestern football's 2025 roster. Learn more about your ad choices. Visit megaphone.fm/adchoices

This happens every so often, and increasingly as the US empire expanded. It comes as a commingling of domestic and foreign policy: Vietnam, The War In Iraq, and now the Israel-Palestinian slaughter.What happens when the interests of the people clash with the interests of the privileged? Biden will be at Morehouse in two weeks. Between now and then, so much is poised to happen.They've literally unleashed police on college students, faculty, observers, and anyone whom the police want to harm. There is no legal justification; this is pure repression. And mass commercial “news” outlets are pushing pure propaganda, no doubt at the behest of owners.Meanwhile, student journalists like at Columbia and UPenn and independent outlets are pushing back. The International Court of Justice could issue arrest warrants for Netanyahu any time now. Israel has seen Columbia and Turkey move to break diplomatic and trade ties. And in Haiti, the attempt to install another US-France-Canada backed interim prime minister has been met with widespread derision.The “elites” (the moneyed and privileged) have lost the power to control the narrative and have dropped all pretenses that they are doing anything other than attempting to suppress by any means necessary.And the end of the school year isn't going to help. Brown and Northwestern had the good sense to put the issue of divestment to a vote, thereby reaching a truce with the students.But we're headed toward the summer, the presidential contest, and the Dem convention in Chicago. Unlike 1968, where King and RFK assassinations fed a wave of discontent that led to Nixon's election and the spiral that we have yet to emerge from, there is a real fascist waiting to assume control of the presidency and push us past the brink.We might be living in the events of the moment that will break the experiment, a moment that portends “national suicide.”JOIN KNARRATIVE: https://www.knarrative.com it's the only way to get into #Knubia, where these classes areheld live with a live chat.To shop Go to:TheGlobalMajorityMore from us:Knarrative Twitter: https://twitter.com/knarrative_Knarrative Instagram: https://www.instagram.com/knarrative/In Class with Carr Twitter: https://twitter.com/inclasswithcarrSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The College Football Experience (@TCEonSGPN) on the Sports Gambling Podcast Network continues its College Football Conference Coach rankings with the Big Ten Conference. Pick Dundee aka (@TheColbyD) & Ryan McIntyre (@Moneyline_Mac) break down all 18 Big Ten Coaches and make sense of where they rank each coach and which ones have proven to be the best and which one need to earn it. Is Ryan Day or Dan Lanning the top coach in the Big Ten Conference? Where does one rank Sherrone Moore after just one season in Ann Arbor? Is Luke Fickell due for a big year or was the Cincinnati Bearcats run just a one hit wonder?Is Curt Cignetti worthy of one of the top spots after just one year at Indiana? Where should one rank Penn State's James Franklin who despite a great record has had his struggles against top notch competition? Is Bret Bielema one of the top coaches in the Big Ten after what he has done in Champaign, Illinois? Should the Iowa Hawkeyes build Kirk Ferentz a statue and where does he rank on our list? Has the Mike Locksley era been a disappointment in College Park, Maryland?Will Jedd Fisch get it going at Washington or was the Arizona gig just a one off? Did DeShaun Foster impress in year at UCLA one despite a losing record? Is Matt Rhule and Greg Schiano two of the best coaches in the conferences? Is Lincoln Riley worthy of the hype he gets or has he inherited great situations? Is Jonathan Smith a guy who will climb up the rankings in his 2nd year at Michigan State? Where does Northwestern's David Braun and Minnesota's PJ Fleck rank in all of this? We talk it all and more on this Big Ten Conference edition of The College Football Experience. 01:12 Welcome to the College Football Experience 01:51 Big 10 Coach Rankings Overview 02:12 Meet the Hosts 02:57 Discussing the Big 10 Coaches 07:30 Ranking the Coaches: Number 18 14:06 Ranking the Coaches: Number 17 20:22 Ranking the Coaches: Number 16 24:25 Ranking the Coaches: Number 15 28:11 Ranking the Coaches: Number 14 32:19 Ranking the Coaches: Number 13 35:16 Michigan's Playoff Prospects 36:35 Luke Fickell's Coaching Journey 37:49 Jonathan Smith's Impact at Oregon State 39:45 Lincoln Riley's Coaching Challenges 46:17 Greg Schiano's Rutgers Revival 48:18 PJ Fleck's Coaching Philosophy 50:59 Top 10 College Football Coaches 01:08:43 Knocking on the Door: The Journey to a National Championship 01:08:57 Controversial Draws and Coaching Lineages 01:09:14 Oregon's Rise and Coaching Comparisons 01:10:46 Ryan Day's Record and Criticisms 01:12:22 James Franklin and Penn State's Challenges 01:17:45 Matt Rhule's Coaching Journey 01:20:51 Bret Bielema's Impact at Illinois 01:23:31 Kirk Ferentz's Consistency at Iowa 01:27:35 Kurt Signetti: A Coaching Phenomenon 01:35:48 Wrapping Up and What's Next JOIN the SGPN community #DegensOnlyExclusive Merch, Contests and Bonus Episodes ONLY on Patreon - https://sg.pn/patreonDiscuss with fellow degens on Discord - https://sg.pn/discordDownload The Free SGPN App - https://sgpn.appCheck out the Sports Gambling Podcast on YouTube - https://sg.pn/YouTubeCheck out our website - http://sportsgamblingpodcast.comSUPPORT us by supporting our partnersUnderdog Fantasy code SGPN - Up to $1000 in BONUS CASH - https://play.underdogfantasy.com/p-sgpnRithmm - Player Props and Picks - Free 7 day trial! http://sportsgamblingpodcast.com/rithmmRebet - Social sportsbook - 100% deposit match promo code SGPN in your app store! ADVERTISE with SGPNInterested in advertising? Contact sales@sgpn.io Follow The College Experience & SGPN On Social MediaTwitter - https://twitter.com/TCEonSGPNInstagram - http://www.instagram.com/TCEonSGPNTikTok - https://www.tiktok.com/@TCEonSGPNYoutube - https://www.youtube.com/@TheCollegeExperienceFollow The Hosts On Social MediaColby Dant - http://www.twitter.com/thecolbydPatty C - https://twitter.com/PattyC831NC Nick - https://twitter.com/NC__NicK Gambling problem? Call 1-800-GAMBLER CO, DC, IL, IN, LA, MD, MS, NJ, OH, PA, TN, VA, WV, WY Call 877-8-HOPENY or text HOPENY (467369) (NY) Call 1-800-327-5050 (MA)21+ to wager. Please Gamble Responsibly. Call 1-800-NEXT-STEP (AZ), 1-800-522-4700 (KS, NV), 1-800 BETS-OFF (IA), 1-800-270-7117 for confidential help (MI)

The College Football Experience (@TCEonSGPN) on the Sports Gambling Podcast Network continues its College Football Conference Coach rankings with the Big Ten Conference. Pick Dundee aka (@TheColbyD) & Ryan McIntyre (@Moneyline_Mac) break down all 18 Big Ten Coaches and make sense of where they rank each coach and which ones have proven to be the best and which one need to earn it. Is Ryan Day or Dan Lanning the top coach in the Big Ten Conference? Where does one rank Sherrone Moore after just one season in Ann Arbor? Is Luke Fickell due for a big year or was the Cincinnati Bearcats run just a one hit wonder?Is Curt Cignetti worthy of one of the top spots after just one year at Indiana? Where should one rank Penn State's James Franklin who despite a great record has had his struggles against top notch competition? Is Bret Bielema one of the top coaches in the Big Ten after what he has done in Champaign, Illinois? Should the Iowa Hawkeyes build Kirk Ferentz a statue and where does he rank on our list? Has the Mike Locksley era been a disappointment in College Park, Maryland?Will Jedd Fisch get it going at Washington or was the Arizona gig just a one off? Did DeShaun Foster impress in year at UCLA one despite a losing record? Is Matt Rhule and Greg Schiano two of the best coaches in the conferences? Is Lincoln Riley worthy of the hype he gets or has he inherited great situations? Is Jonathan Smith a guy who will climb up the rankings in his 2nd year at Michigan State? Where does Northwestern's David Braun and Minnesota's PJ Fleck rank in all of this? We talk it all and more on this Big Ten Conference edition of The College Football Experience. 01:12 Welcome to the College Football Experience 01:51 Big 10 Coach Rankings Overview 02:12 Meet the Hosts 02:57 Discussing the Big 10 Coaches 07:30 Ranking the Coaches: Number 18 14:06 Ranking the Coaches: Number 17 20:22 Ranking the Coaches: Number 16 24:25 Ranking the Coaches: Number 15 28:11 Ranking the Coaches: Number 14 32:19 Ranking the Coaches: Number 13 35:16 Michigan's Playoff Prospects 36:35 Luke Fickell's Coaching Journey 37:49 Jonathan Smith's Impact at Oregon State 39:45 Lincoln Riley's Coaching Challenges 46:17 Greg Schiano's Rutgers Revival 48:18 PJ Fleck's Coaching Philosophy 50:59 Top 10 College Football Coaches 01:08:43 Knocking on the Door: The Journey to a National Championship 01:08:57 Controversial Draws and Coaching Lineages 01:09:14 Oregon's Rise and Coaching Comparisons 01:10:46 Ryan Day's Record and Criticisms 01:12:22 James Franklin and Penn State's Challenges 01:17:45 Matt Rhule's Coaching Journey 01:20:51 Bret Bielema's Impact at Illinois 01:23:31 Kirk Ferentz's Consistency at Iowa 01:27:35 Kurt Signetti: A Coaching Phenomenon 01:35:48 Wrapping Up and What's Next Exclusive SGPN Bonuses And Linkshttp://linktr.ee/sportsgamblingpodcastFollow The Sports Gambling Podcast X/Twitter - https://x.com/GamblingPodcastInstagram - https://www.instagram.com/sportsgamblingpodcastTikTok - https://www.tiktok.com/@gamblingpodcastFacebook - http://www.facebook.com/sportsgamblingpodcastFollow The Sports Gambling Podcast HostsSean Green - http://www.twitter.com/seantgreenRyan Kramer - http://www.twitter.com/kramercentricGambling problem? Call 1-800-GAMBLER CO, DC, IL, IN, LA, MD, MS, NJ, OH, PA, TN, VA, WV, WY Call 877-8-HOPENY or text HOPENY (467369) (NY) Call 1-800-327-5050 (MA)21+ to wager. Please Gamble Responsibly. Call 1-800-NEXT-STEP (AZ), 1-800-522-4700 (KS, NV), 1-800 BETS-OFF (IA), 1-800-270-7117 for confidential help (MI)

It's 2025, and yet again, people are claiming that graduate school doesn't help your career anymore. But is that true? Dr. Don Martin has been a Dean of Admissions at Columbia, University of Chicago Booth, and Northwestern, and is the author of the book Grad School Road Map - and he's overseen the admission of tens of thousands of students. In this episode, Dr. Martin shares how the job market affects graduate degrees and vise versa, what to make of the current job market, and why graduate school is still a great idea. Achievable is a modern test prep platform for the GRE exam - visit https://achievable.me to try our course for free.

Northwestern University President Michael Schill was called to Congress for questioning — again. Crain's higher education reporter Brandon Dupré discusses with host Amy Guth.Plus: Judge probes whether Trump retaliated against Jenner & Block, what American Airlines says about its battle with United at O'Hare, Advocate doctors to drop Blue Cross Illinois HMO plan and United Airlines just unveiled its exclusive Polaris lounge makeover.

The most powerful person in the world is the storyteller. Steve Jobs believed this, and it's never been more accurate, especially in healthcare. Renowned storytelling expert Craig Wortmann—Professor at Northwestern's Kellogg School of Management and CEO of Sales Engine joins Eric Glazer to discuss one of the most underutilized leadership tools in healthcare: storytelling. During the episode, Craig shares a practical framework—Collect, Categorize, Construct, Convey—to help healthcare leaders use storytelling to drive action, inspire change, and connect more deeply with teams and stakeholders. You'll learn: Why stories persuade better than data The four types of stories every leader should tell How to embed storytelling into your leadership routine Plus, Craig explains how failure stories can actually build trust—and why storytelling is a leadership discipline, not just an art.   About Craig One of the most respected voices in storytelling and leadership, Craig Wortmann is an award-winning educator, three-time entrepreneur, author and CEO. Craig is also  Clinical Professor of Innovation & Entrepreneurship at Northwestern's Kellogg School of Management and the Founder & Academic Director of the Kellogg Sales Institute.    He founded Sales Engine, a tools and services firm founded on the principle that leaders should treat sales as the engine of their business, in 2009. Craig and his team consult to the world's largest and most successful companies, as well as some of the world's fastest-growing entrepreneurial companies.   Craig is author of What's Your Story™? a book that helps people tell the right story at the right time for the right reasons. You can learn more about Craig here: https://www.linkedin.com/in/craigwortmann/ About Bright Spots in Healthcare Bright Spots in Healthcare is produced by Bright Spots Ventures Bright Spots Ventures brings healthcare leaders together to share working solutions or "bright spots" to common challenges. We build valuable and meaningful relationships through our Bright Spots in Healthcare podcast, webinar series, leadership councils, customized peer events, and sales and go-to-market consulting. We believe that finding a bright spot and cloning it is the most effective strategy to improve healthcare in our lifetime. Visit our website at www.brightspotsinhealthcare.com

A CMO Confidential Interview with Jim Lecinski, Clinical Professor of Marketing at the Kellogg School of Management, two time author, and former Google VP. Jim discusses the need to teach both durable and perishable knowledge, the importance of faculty composition, why students should "sample" B-Schools, and how the Northwestern "House Design" keeps it ranked as the #1 marketing school. We go inside the Insomnia Cookies Case which uses GOST (Goals, Objectives, Strategy and Tactics) and 70/20/10 to train students on driving revenue, profit and market share. Tune in to hear why you shouldn't be a "Tumbleweed" and instead strive to "Meet the universe halfway."See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Bison may no longer be on the brink of extinction, but their journey is far from over. With dwindling genetic diversity and the absence of natural selection, these prairie ecosystem engineers are not as wild as they once were. In this episode, Dr. Daniel Kinka, director of rewilding at American Prairie, shares the story of bison—from their near extinction due to westward expansion to their return to the plains. We also learn why bison rewilding is essential to restoring biodiversity and ensuring the prairie thrives for generations to come. Bonus Track: Jen Osburn Eliot at Oregon Zoo shares how they're helping Northwestern pond turtles grow strong in a program that raises and releases them back into the wild.    To learn more about Wild Kingdom, check out the website.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Today is another episode in our series about moms in honor of Every Mother Counts. Today we talk to the iconic Cindy Crawford, an old friend of Christy's (you may have seen them together in the Apple TV docu-series The Super Models). Cindy is a Midwestern girl, a high school valedictorian who started at Northwestern on an academic scholarship to study chemical engineering before her career took her around the world. She is also the daughter of Jenny, a young bride who had four children and lost one to childhood leukemia. This is a candid and loving conversation about the realities of family life. Please share. (Previously aired) This series hopes to raise $100,000 to support safe and respectful pregnancy, delivery and postpartum care in 9 countries through Every Mother Counts, founded in 2010 and led every day since by Christy Turlington Burns. Please join us with a donation here. We know that maternal health is a human right; let's help make it ubiquitous. Love it? Don't like it? Have an idea? We love to hear from listeners. Write us anytime — hello@kellycorrigan.com - or sign up for our weekly list of takeaways here. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

In this week's episode of the Husker247 Nebraska Baseball Podcast, we discuss Nebraska's series win over Northwestern last weekend, a midweek loss to Kansas where Nebraska didn't have much to show for good at-bats and preview the upcoming series at Maryland. In the second segment, Husker247's Mike Schaefer joins to discuss the Husker baseball season and much more. Listen in! To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

When most of us woke up Wednesday morning, President Donald Trump was still very excited about the tariffs he imposed on dozens of countries that had gone into effect just after midnight eastern time. At the National Republican Congressional Committee dinner the night before, he even claimed the scheme would be ‘legendary in a positive way' and bragged, ‘These countries are calling us up. Kissing my ass.' But by Wednesday afternoon, Trump had blinked, announcing a 90-day pause on nearly all of the ‘reciprocal' tariffs he unveiled last week (China was the exception; he boosted tariffs to 125 percent after Beijing retaliated with it's own reciprocal tariffs). Alex Jacquez, chief of policy and advocacy at the progressive think tank Groundwork Collaborative and a member of former President Biden's White House National Economic Council, explains why all this volatility leaves America worse off economically.And in headlines: Michigan Gov. Gretchen Whitmer made an uncomfortable guest appearance in the Oval Office, The White House said it's freezing hundreds of millions in federal funding for Cornell and Northwestern universities, and two federal judges put limits on the Trump administration's use of the Alien Enemies Act to deport alleged foreign gang members.Show Notes:Subscribe to the What A Day Newsletter – https://tinyurl.com/3kk4nyz8What A Day – YouTube – https://www.youtube.com/@whatadaypodcastFollow us on Instagram – https://www.instagram.com/crookedmedia/For a transcript of this episode, please visit crooked.com/whataday